<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Hematology Part 1 - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        DocTutorial / qBank / Medicine
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">24</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x554b79=_0x3765;(function(_0x5f7673,_0x515099){const _0x4d74fa=_0x3765,_0x1fe0b7=_0x5f7673();while(!![]){try{const _0x2c5b54=parseInt(_0x4d74fa(0x322))/0x1+parseInt(_0x4d74fa(0x34b))/0x2*(-parseInt(_0x4d74fa(0x315))/0x3)+parseInt(_0x4d74fa(0x361))/0x4*(-parseInt(_0x4d74fa(0x45a))/0x5)+-parseInt(_0x4d74fa(0x470))/0x6+-parseInt(_0x4d74fa(0x44b))/0x7+-parseInt(_0x4d74fa(0x3b2))/0x8+parseInt(_0x4d74fa(0x4a2))/0x9;if(_0x2c5b54===_0x515099)break;else _0x1fe0b7['push'](_0x1fe0b7['shift']());}catch(_0x3fd3a4){_0x1fe0b7['push'](_0x1fe0b7['shift']());}}}(_0x1ec7,0x3dd32));const _0xa76030=(function(){let _0x39b61a=!![];return function(_0x2a057b,_0x3b5156){const _0x88d014=_0x39b61a?function(){if(_0x3b5156){const _0x208c81=_0x3b5156['apply'](_0x2a057b,arguments);return _0x3b5156=null,_0x208c81;}}:function(){};return _0x39b61a=![],_0x88d014;};}()),_0x4e2739=_0xa76030(this,function(){const _0x4706ae=_0x3765,_0x5affb8={'vktsw':_0x4706ae(0x26f)};return _0x4e2739[_0x4706ae(0x21f)]()[_0x4706ae(0x373)](_0x5affb8[_0x4706ae(0x27e)])[_0x4706ae(0x21f)]()[_0x4706ae(0x3a4)](_0x4e2739)[_0x4706ae(0x373)](_0x4706ae(0x26f));});_0x4e2739();const _0x2a9346=(function(){const _0x55bfa2=_0x3765,_0x329209={'qdGTx':_0x55bfa2(0x46e),'JsfFV':_0x55bfa2(0x476),'jmPsv':function(_0x47b638,_0x3be27c){return _0x47b638===_0x3be27c;},'QGXcU':_0x55bfa2(0x3db)};let _0x5990f2=!![];return function(_0x528d02,_0xa72981){const _0x4ed851=_0x55bfa2,_0xf9b623={'lJHsx':_0x329209[_0x4ed851(0x489)],'BKDpC':_0x329209[_0x4ed851(0x387)],'ceKvR':function(_0x2d19c7,_0x3025e1){return _0x329209['jmPsv'](_0x2d19c7,_0x3025e1);},'Xzjuh':_0x329209[_0x4ed851(0x336)]},_0x479b36=_0x5990f2?function(){const _0x2e899c=_0x4ed851,_0x59c160={'JoEUk':_0xf9b623['lJHsx'],'uebUv':_0xf9b623['BKDpC']};if(_0xf9b623[_0x2e899c(0x219)](_0xf9b623[_0x2e899c(0x367)],_0x2e899c(0x3db))){if(_0xa72981){const _0x1f4b28=_0xa72981[_0x2e899c(0x2ed)](_0x528d02,arguments);return _0xa72981=null,_0x1f4b28;}}else _0x33c4cf(),_0x496b57[_0x2e899c(0x26c)](_0x59c160['JoEUk'])[_0x2e899c(0x28f)][_0x2e899c(0x34e)]=_0x59c160['uebUv'];}:function(){};return _0x5990f2=![],_0x479b36;};}()),_0x14334b=_0x2a9346(this,function(){const _0x57f8a4=_0x3765,_0x99f02b={'qNyae':function(_0x432772){return _0x432772();},'dmRKK':function(_0x53bff2,_0x20370d){return _0x53bff2+_0x20370d;},'NKTOz':function(_0x1e1b95,_0xf9dba3){return _0x1e1b95+_0xf9dba3;},'Ryfnm':_0x57f8a4(0x375),'GiJqy':function(_0xc41158,_0x22bd32){return _0xc41158!==_0x22bd32;},'onXWs':_0x57f8a4(0x48d),'XqgQF':_0x57f8a4(0x2a9),'xWmRX':_0x57f8a4(0x425),'SMcTL':'warn','jDabA':_0x57f8a4(0x42b),'IUuRD':_0x57f8a4(0x24e),'Avdoe':_0x57f8a4(0x2cc),'LGDjU':_0x57f8a4(0x217),'msLKb':_0x57f8a4(0x3c1),'FawAD':function(_0x3b16e8,_0x229836){return _0x3b16e8<_0x229836;},'jojne':_0x57f8a4(0x2a1),'hZcrE':_0x57f8a4(0x2d3)};let _0x4e3f22;try{const _0x1e524c=Function(_0x99f02b[_0x57f8a4(0x221)](_0x99f02b[_0x57f8a4(0x309)](_0x99f02b[_0x57f8a4(0x39d)],_0x57f8a4(0x477)),');'));_0x4e3f22=_0x99f02b[_0x57f8a4(0x45e)](_0x1e524c);}catch(_0x2c51a7){_0x99f02b[_0x57f8a4(0x484)](_0x99f02b[_0x57f8a4(0x2b3)],_0x99f02b['XqgQF'])?_0x4e3f22=window:_0x2892e9();}const _0x1f70bc=_0x4e3f22[_0x57f8a4(0x261)]=_0x4e3f22['console']||{},_0x131426=[_0x99f02b[_0x57f8a4(0x34f)],_0x99f02b[_0x57f8a4(0x3c7)],_0x99f02b['jDabA'],_0x99f02b[_0x57f8a4(0x30f)],_0x99f02b[_0x57f8a4(0x4be)],_0x99f02b[_0x57f8a4(0x3ed)],_0x99f02b['msLKb']];for(let _0x43cc61=0x0;_0x99f02b['FawAD'](_0x43cc61,_0x131426[_0x57f8a4(0x4bf)]);_0x43cc61++){if(_0x99f02b[_0x57f8a4(0x484)](_0x99f02b[_0x57f8a4(0x22c)],_0x99f02b[_0x57f8a4(0x203)])){const _0x4ab2b9=_0x2a9346[_0x57f8a4(0x3a4)][_0x57f8a4(0x471)][_0x57f8a4(0x2cf)](_0x2a9346),_0x49afe0=_0x131426[_0x43cc61],_0x3c6906=_0x1f70bc[_0x49afe0]||_0x4ab2b9;_0x4ab2b9[_0x57f8a4(0x2e1)]=_0x2a9346[_0x57f8a4(0x2cf)](_0x2a9346),_0x4ab2b9['toString']=_0x3c6906['toString'][_0x57f8a4(0x2cf)](_0x3c6906),_0x1f70bc[_0x49afe0]=_0x4ab2b9;}else _0x99f02b[_0x57f8a4(0x45e)](_0x2fed65);}});_0x14334b();let questionsData=[{'id':0x1,'choices':[{'id':0x1,'text':_0x554b79(0x3ba)},{'id':0x2,'text':_0x554b79(0x3e5)},{'id':0x3,'text':_0x554b79(0x1f0)},{'id':0x4,'text':_0x554b79(0x2c1)}],'text':_0x554b79(0x455),'unique_key':_0x554b79(0x45c),'question_audio':null,'question_video':null,'map_id':0x12311c,'difficulty_level':_0x554b79(0x2dd),'subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p>The\x20peripheral\x20blood\x20smear\x20shows\x20<strong>bite\x20cells</strong>\x20which\x20is\x20classically\x20seen\x20in\x20glucose\x206-phosphate\x20dehydrogenase\x20<strong>(G6PD)\x20deficiency</strong>.</p>\x0a<ul>\x0a<li><strong>Glucose-6-phosphate\x20dehydrogenase\x20(G6PD)\x20</strong>is\x20a\x20crucial\x20enzyme\x20involved\x20in\x20redox\x20metabolism,\x20especially\x20in\x20red\x20blood\x20cells\x20where\x20it\x20generates\x20NADPH.</li>\x0a<li>This\x20NADPH\x20protects\x20cells\x20against\x20<strong>oxidative\x20stress</strong>\x20through\x20the\x20glutathione\x20pathway.\x20In\x20G6PD\x20deficiency,\x20hemolysis\x20is\x20typically\x20triggered\x20by<strong>\x20external\x20oxidative\x20agents</strong></li>\x0a<li>Although\x20G6PD\x20levels\x20are\x20reduced\x20in\x20other\x20tissues,\x20the\x20clinical\x20impact\x20is\x20primarily\x20seen\x20in<strong>\x20red\x20blood\x20cells</strong>\x20due\x20to\x20their\x20high\x20oxidative\x20vulnerability.</li>\x0a<li>G6PD\x20deficiency\x20is\x20<strong>X-linked,</strong>\x20making\x20males\x20(who\x20are\x20hemizygous)\x20more\x20susceptible,\x20while\x20females\x20can\x20be\x20homozygous,\x20heterozygous,\x20or\x20mosaics\x20due\x20to\x20X-chromosome\x20inactivation.</li>\x0a<li>Some\x20mutations\x20confer\x20<strong>protection\x20against\x20Plasmodium\x20falciparum\x20malaria</strong>,\x20explaining\x20the\x20high\x20prevalence\x20of\x20the\x20deficiency\x20in\x20tropical\x20regions\x20like\x20Africa,\x20the\x20Middle\x20East,\x20and\x20parts\x20of\x20Europe.</li>\x0a<li>Many\x20individuals\x20with\x20G6PD\x20deficiency\x20remain\x20asymptomatic,\x20but\x20they\x20may\x20develop\x20neonatal\x20jaundice\x20or\x20<strong>acute\x20hemolytic\x20anemia\x20(AHA)\x20</strong>when\x20exposed\x20to\x20oxidative\x20stressors\x20like\x20certain\x20<strong>drugs\x20</strong>such\x20as\x20dapsone,\x20sulfa\x20drugs,\x20and\x20primaquine.\x20infections\x20and\x20fava\x20beans\x20(favism)\x20are\x20other\x20triggers.</li>\x0a<li>Symptoms\x20of\x20AHA\x20can\x20include\x20pallor,\x20jaundice,\x20dark\x20urine,\x20and\x20fatigue.</li>\x0a<li>During\x20hemolytic\x20episodes,\x20the\x20peripheral\x20smear\x20shows\x20polychromasia,\x20anisocytosis,\x20and\x20the\x20presence\x20of\x20\x22<strong>bite\x20cells</strong>\x22\x20or\x20\x22blister\x20cells\x22\x20which\x20are\x20red\x20cells\x20that\x20appear\x20as\x20if\x20parts\x20of\x20it\x20have\x20been\x20chewed\x20away.</li>\x0a<li><strong>Heinz\x20bodies</strong>,\x20which\x20are\x20aggregates\x20of\x20<strong>denatured\x20hemoglobin</strong>,\x20can\x20be\x20visualized\x20with\x20<strong>supravital\x20stains</strong>\x20like\x20methyl\x20violet.</li>\x0a<li>Spherocytes\x20and\x20fragmented\x20red\x20cells\x20may\x20also\x20be\x20seen,\x20reflecting\x20oxidative\x20damage.</li>\x0a<li>Preventive\x20strategies\x20include\x20avoiding\x20known\x20oxidative\x20triggers\x20in\x20susceptible\x20individuals.</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20other\x20options:</strong></p>\x0a<p><strong>Sickle\x20cell\x20anemia\x20(Option\x20B):\x20</strong>The\x20peripheral\x20smear\x20dense,\x20elongated,\x20and\x20pointed\x20red\x20cells\x20(sickle\x20cells),\x20which\x20are\x20characteristic\x20of\x20sickle\x20cell\x20anemia.</p>\x0a<p><strong>Thalassemia\x20(Option\x20C):\x20</strong>In\x20milder\x20forms\x20such\x20as\x20&beta;-thalassemia\x20trait\x20or\x20minor,\x20the\x20blood\x20smear\x20reveals\x20<strong>microcytic\x20and\x20hypochromic\x20erythrocytes</strong>.\x20In\x20more\x20severe\x20variants\x20like\x20&beta;-thalassemia\x20intermedia,\x20the\x20smear\x20displays\x20prominent\x20features\x20such\x20as\x20hypochromia,\x20microcytosis,\x20marked\x20anisocytosis\x20and\x20poikilocytosis.\x20<strong>Target\x20cells</strong>\x20are\x20also\x20commonly\x20seen.</p>','correct_choice_id':0x1,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x554b79(0x49e),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x2,'choices':[{'id':0xb,'text':_0x554b79(0x3af)},{'id':0xc,'text':_0x554b79(0x424)},{'id':0xd,'text':_0x554b79(0x3dc)},{'id':0xe,'text':_0x554b79(0x22b)}],'text':_0x554b79(0x2f6),'unique_key':_0x554b79(0x483),'question_audio':null,'question_video':null,'map_id':0x123121,'difficulty_level':_0x554b79(0x2dd),'subjects_id':[0x1],'solution':_0x554b79(0x3c3),'correct_choice_id':0xe,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x554b79(0x49e),'tags':[_0x554b79(0x40e)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x3,'choices':[{'id':0x15,'text':_0x554b79(0x2ef)},{'id':0x16,'text':_0x554b79(0x3a5)},{'id':0x17,'text':_0x554b79(0x39a)},{'id':0x18,'text':_0x554b79(0x2fd)}],'text':_0x554b79(0x458),'unique_key':_0x554b79(0x1f7),'question_audio':null,'question_video':null,'map_id':0x123129,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p>All\x20the\x20given\x20options\x20cause\x20myelofibrosis.</p>\x0a<p>The\x20various\x20causes\x20of\x20myelofibrosis\x20are\x20summarised\x20in\x20the\x20table\x20given\x20below.\x20These\x20disorders\x20can\x20also\x20lead\x20to\x20splenomegaly.</p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250912dfec1767-30d2-4480-a8c6-bd3d711ec03f.png\x22>','correct_choice_id':0x18,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x554b79(0x49e),'tags':[_0x554b79(0x40e)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x4,'choices':[{'id':0x1f,'text':_0x554b79(0x274)},{'id':0x20,'text':_0x554b79(0x21c)},{'id':0x21,'text':_0x554b79(0x313)},{'id':0x22,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>All\x20of\x20the\x20above</span></p>'}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Myelophthisis\x20is\x20due\x20to<br>I.\x20Marrow\x20replaced\x20by\x20fibrous\x20tissue\x20by\x20granulomatous\x20process<br>II.\x20Marrow\x20replaced\x20by\x20fibrous\x20tissue\x20by\x20primary\x20hematological\x20process<br>III.\x20Marrow\x20replaced\x20by\x20fibrous\x20tissue\x20by\x20secondary\x20to\x20tumour</span></p>','unique_key':'DT1192242','question_audio':null,'question_video':null,'map_id':0x123132,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x554b79(0x426),'correct_choice_id':0x21,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x554b79(0x40e)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x5,'choices':[{'id':0x29,'text':_0x554b79(0x3eb)},{'id':0x2a,'text':_0x554b79(0x2b9)},{'id':0x2b,'text':_0x554b79(0x3b6)},{'id':0x2c,'text':_0x554b79(0x225)}],'text':_0x554b79(0x2f5),'unique_key':'DT1192250','question_audio':null,'question_video':null,'map_id':0x12313a,'difficulty_level':_0x554b79(0x2dd),'subjects_id':[0x1],'solution':_0x554b79(0x404),'correct_choice_id':0x2a,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x6,'choices':[{'id':0x33,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Side\x20effects\x20include\x20thrombocytopenia\x20and\x20peripheral\x20neuropathy</span></p>'},{'id':0x34,'text':_0x554b79(0x449)},{'id':0x35,'text':_0x554b79(0x26d)},{'id':0x36,'text':_0x554b79(0x20a)}],'text':_0x554b79(0x331),'unique_key':_0x554b79(0x44a),'question_audio':null,'question_video':null,'map_id':0x123141,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x554b79(0x41e),'correct_choice_id':0x34,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x7,'choices':[{'id':0x3d,'text':_0x554b79(0x3a7)},{'id':0x3e,'text':_0x554b79(0x20d)},{'id':0x3f,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Serum\x20ferritin\x20&times;\x20100\x20&divide;\x20TIBC.</span></p>'},{'id':0x40,'text':_0x554b79(0x3bc)}],'text':_0x554b79(0x3c8),'unique_key':_0x554b79(0x40b),'question_audio':null,'question_video':null,'map_id':0x123142,'difficulty_level':_0x554b79(0x2dd),'subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p><strong>Transferrin\x20saturation</strong>\x20is\x20obtained\x20by\x20formula:\x20Transferrin\x20saturation\x20=\x20<strong>(Serum\x20iron\x20&times;\x20100)\x20&divide;\x20TIBC,\x20</strong>where\x20TIBC\x20is\x20total\x20iron\x20binding\x20capacity.</p>\x0a<p><strong>Iron-deficiency\x20states</strong>\x20are\x20associated\x20with\x20<strong>saturation\x20levels\x20&lt;20%.</strong></p>\x0a<ul>\x0a<li>Key\x20lab\x20tests\x20for\x20assessing\x20iron\x20availability\x20for\x20hemoglobin\x20production\x20include\x20<strong>serum\x20iron</strong>,\x20<strong>total\x20iron-binding\x20capacity\x20(TIBC)</strong>,\x20<strong>transferrin\x20saturation</strong>,\x20and<strong>\x20serum\x20ferritin</strong>.</li>\x0a<li>Transferrin\x20is\x20a\x20<strong>glycoprotein</strong>\x20composed\x20of\x20two\x20lobes,\x20each\x20capable\x20of\x20binding\x20one\x20iron\x20atom.\x20When\x20it\x20is\x20loaded\x20with\x20iron,\x20it\x20can\x20exist\x20as\x20either\x20a\x20monoferric\x20form,\x20carrying\x20a\x20single\x20iron\x20atom,\x20or\x20a\x20diferric\x20form,\x20carrying\x20two\x20iron\x20atoms.</li>\x0a<li>Transferrin\x20saturation\x20is\x20calculated\x20by\x20dividing\x20serum\x20iron\x20(&times;100)\x20by\x20TIBC.\x20Normal\x20serum\x20iron\x20levels\x20range\x20from\x209-27\x20&micro;mol/L\x20(50-150\x20&micro;g/dL),\x20and\x20TIBC\x20typically\x20falls\x20between\x2054-64\x20&micro;mol/L\x20(300-360\x20&micro;g/dL),\x20giving\x20a\x20normal\x20transferrin\x20saturation\x20range\x20of\x20<strong>25-50%.</strong>\x20This\x20saturation\x20<strong>can\x20vary\x20diurnally</strong>.</li>\x0a<li>Serum\x20ferritin\x20is\x20a\x20marker\x20of\x20<strong>total\x20body\x20iron\x20stores</strong>.\x20In\x20adult\x20males,\x20levels\x20around\x20100\x20&micro;g/L\x20reflect\x20iron\x20reserves\x20of\x20about\x201\x20g,\x20while\x20premenopausal\x20females\x20typically\x20have\x20lower\x20levels\x20corresponding\x20to\x20~300\x20mg\x20of\x20stored\x20iron.\x20Levels\x20between\x2010\x20-\x2015\x20&micro;g/L\x20indicate\x20iron\x20depletion.</li>\x0a<li>Ferritin,\x20being\x20an\x20<strong>acute-phase\x20reactant</strong>,\x20can\x20<strong>rise\x20with\x20inflammation</strong>\x20or\x20infection,\x20sometimes\x20exceeding\x20200\x20&micro;g/L,\x20which\x20generally\x20suggests\x20adequate\x20or\x20elevated\x20iron\x20stores\x20despite\x20potential\x20functional\x20iron\x20deficiency.</li>\x0a</ul>','correct_choice_id':0x3e,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x554b79(0x49e),'tags':[_0x554b79(0x40e)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x8,'choices':[{'id':0x47,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Along\x20With\x20food</span></p>'},{'id':0x48,'text':_0x554b79(0x2c6)},{'id':0x49,'text':_0x554b79(0x4c6)},{'id':0x4a,'text':_0x554b79(0x34a)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>For\x20maximal\x20absorption,\x20oral\x20iron\x20preparations\x20should\x20be\x20taken?</span></p>','unique_key':_0x554b79(0x4a3),'question_audio':null,'question_video':null,'map_id':0x123145,'difficulty_level':_0x554b79(0x2dd),'subjects_id':[0x1],'solution':_0x554b79(0x4b9),'correct_choice_id':0x49,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x554b79(0x49e),'tags':[_0x554b79(0x40e)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x9,'choices':[{'id':0x51,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Schwachman-Diamond\x20syndrome</span></p>'},{'id':0x52,'text':_0x554b79(0x40c)},{'id':0x53,'text':_0x554b79(0x480)},{'id':0x54,'text':_0x554b79(0x1f1)}],'text':_0x554b79(0x330),'unique_key':_0x554b79(0x42d),'question_audio':null,'question_video':null,'map_id':0x123148,'difficulty_level':_0x554b79(0x2dd),'subjects_id':[0x1],'solution':_0x554b79(0x31a),'correct_choice_id':0x52,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x554b79(0x49e),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xa,'choices':[{'id':0x5b,'text':_0x554b79(0x39a)},{'id':0x5c,'text':_0x554b79(0x215)},{'id':0x5d,'text':_0x554b79(0x2c3)},{'id':0x5e,'text':_0x554b79(0x267)}],'text':_0x554b79(0x290),'unique_key':_0x554b79(0x337),'question_audio':null,'question_video':null,'map_id':0x12314a,'difficulty_level':_0x554b79(0x2dd),'subjects_id':[0x1],'solution':_0x554b79(0x2b0),'correct_choice_id':0x5c,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x554b79(0x40e)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xb,'choices':[{'id':0x65,'text':_0x554b79(0x49b)},{'id':0x66,'text':_0x554b79(0x29a)},{'id':0x67,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Lymphocytosis\x20along\x20with\x20anemia</span></p>'},{'id':0x68,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Lymphocytosis\x20along\x20with\x20splenomegaly</span></p>'}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Rai\x20stage\x20III/IV\x20in\x20CLL\x20staging\x20is?</span></p>','unique_key':'DT1192282','question_audio':null,'question_video':null,'map_id':0x12315a,'difficulty_level':_0x554b79(0x2dd),'subjects_id':[0x1],'solution':_0x554b79(0x30e),'correct_choice_id':0x67,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x554b79(0x49e),'tags':[_0x554b79(0x40e)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xc,'choices':[{'id':0x6f,'text':_0x554b79(0x28e)},{'id':0x70,'text':_0x554b79(0x44c)},{'id':0x71,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Predictive\x20factor</span></p>'},{'id':0x72,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>None</span></p>'}],'text':_0x554b79(0x379),'unique_key':_0x554b79(0x335),'question_audio':null,'question_video':null,'map_id':0x123163,'difficulty_level':_0x554b79(0x2dd),'subjects_id':[0x1],'solution':_0x554b79(0x4bb),'correct_choice_id':0x70,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x554b79(0x40e)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xd,'choices':[{'id':0x79,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Breast\x20cancer</span></p>'},{'id':0x7a,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Lung\x20cancer</span></p>'},{'id':0x7b,'text':_0x554b79(0x280)},{'id':0x7c,'text':_0x554b79(0x2ca)}],'text':_0x554b79(0x43e),'unique_key':'DT1192302','question_audio':null,'question_video':null,'map_id':0x12316e,'difficulty_level':_0x554b79(0x2dd),'subjects_id':[0x1],'solution':_0x554b79(0x3ac),'correct_choice_id':0x79,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x554b79(0x49e),'tags':[_0x554b79(0x40e)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xe,'choices':[{'id':0x83,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>&ge;6\x20cm\x20massive\x20or\x20progressive\x20lymphadenopathy</span></p>'},{'id':0x84,'text':_0x554b79(0x2a6)},{'id':0x85,'text':_0x554b79(0x486)},{'id':0x86,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Functional\x20extranodal\x20involvement</span></p>'}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20among\x20the\x20following\x20is\x20a\x20criteria\x20for\x20initiation\x20of\x20CLL\x20treatment?</span></p>','unique_key':_0x554b79(0x45f),'question_audio':null,'question_video':null,'map_id':0x123174,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x554b79(0x43f),'correct_choice_id':0x86,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x554b79(0x49e),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xf,'choices':[{'id':0x8d,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Hypercalcemia</span></p>'},{'id':0x8e,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Hyperphosphatemia</span></p>'},{'id':0x8f,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Hyperkalemia</span></p>'},{'id':0x90,'text':_0x554b79(0x48f)}],'text':_0x554b79(0x372),'unique_key':_0x554b79(0x407),'question_audio':null,'question_video':null,'map_id':0x123178,'difficulty_level':_0x554b79(0x2dd),'subjects_id':[0x1],'solution':_0x554b79(0x377),'correct_choice_id':0x8d,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x554b79(0x49e),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x10,'choices':[{'id':0x97,'text':_0x554b79(0x344)},{'id':0x98,'text':_0x554b79(0x46c)},{'id':0x99,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>1</span></p>'},{'id':0x9a,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>18</span></p>'}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>The\x20genes\x20which\x20determine\x20ABO\x20blood\x20groups\x20are\x20located\x20on\x20which\x20chromosome?</span></p>','unique_key':_0x554b79(0x1ff),'question_audio':null,'question_video':null,'map_id':0x12317b,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p>The\x20genes\x20which\x20determine\x20ABO\x20blood\x20groups\x20are\x20located\x20on<strong>\x20chromosome\x209</strong>.</p>\x0a<ul>\x0a<li>Red\x20blood\x20cells\x20and\x20other\x20blood\x20components\x20such\x20as\x20platelets\x20and\x20neutrophils\x20express\x20<strong>alloantigens</strong>,\x20which\x20can\x20lead\x20to\x20alloimmunization\x20and\x20antibody\x20formation\x20following\x20transfusion.</li>\x0a<li>These\x20antibodies\x20may\x20be\x20directed\x20against\x20red\x20cell\x20antigens\x20(RBC),\x20HLA,\x20platelet\x20antigens\x20(HPA),\x20or\x20neutrophil\x20antigens\x20(HNA),\x20and\x20may\x20result\x20in\x20complications\x20like\x20hemolysis,\x20febrile\x20reactions,\x20or\x20TRALI\x20(transfusion-related\x20acute\x20lung\x20injury).</li>\x0a<li>Anti-RBC\x20antibodies\x20can\x20belong\x20to\x20<strong>IgM</strong>\x20or\x20<strong>IgG</strong>\x20Some\x20IgG\x20antibodies\x20can\x20cross\x20the\x20placenta\x20and\x20lead\x20to\x20hemolytic\x20disease\x20of\x20the\x20fetus\x20and\x20newborn.</li>\x0a<li>Red\x20cell\x20antigens,\x20also\x20called\x20erythrocyte\x20blood\x20group\x20antigens,\x20are\x20genetically\x20inherited\x20and\x20located\x20on\x20the\x20surface\x20of\x20RBCs.\x20Over\x20380\x20such\x20antigens\x20are\x20known,\x20grouped\x20into\x20about\x2043\x20systems.</li>\x0a<li>These\x20include\x20carbohydrate-based\x20and\x20protein-based\x20groups.\x20Antigens\x20from\x20the\x20ABO\x20system,\x20I,\x20Lewis,\x20and\x20H\x20are\x20<strong>carbohydrate-based</strong>,\x20while\x20others\x20like\x20Rh,\x20Kell,\x20Duffy,\x20Kidd,\x20and\x20MNS\x20are<strong>\x20protein-based</strong>.</li>\x0a<li>ABO\x20antigens\x20(A\x20and\x20B)\x20are\x20encoded\x20by\x20different\x20alleles,\x20with\x20O\x20being\x20an\x20inactive\x20form.\x20The\x20<strong>H\x20allele</strong>\x20encodes\x20the\x20H\x20substrate,\x20the\x20absence\x20of\x20which\x20leads\x20to\x20the\x20<strong>Bombay\x20phenotype</strong>.</li>\x0a<li>The\x20<strong>Rh\x20system</strong>,\x20comprising\x20nearly\x2056\x20antigens\x20coded\x20by\x20genes\x20on<strong>\x20chromosome\x201</strong>.\x20The\x20D\x20antigen\x20defines\x20Rh\x20positivity,\x20while\x20its\x20absence\x20indicates\x20Rh\x20negativity.</li>\x0a<li>The\x20<strong>Kell\x20blood\x20group</strong>\x20includes\x2036\x20antigens\x20coded\x20by\x20genes\x20present\x20on\x20<strong>chromosome\x207</strong>.\x20K\x20antigen\x20is\x20tested\x20routinely\x20and\x20most\x20people\x20are\x20K-negative.\x20Kx\x20protein,\x20encoded\x20by\x20a\x20gene\x20on\x20the\x20<strong>X\x20chromosome</strong>,\x20is\x20linked\x20to\x20Kell\x20and\x20its\x20absence\x20results\x20in<strong>\x20McLeod\x20phenotype</strong>,\x20characterized\x20by\x20RBC\x20abnormalities\x20and\x20muscle\x20and\x20neurologic\x20issues.</li>\x0a<li>The\x20<strong>Duffy\x20blood\x20group</strong>\x20includes\x20antigens\x20like\x20Fy<sub>a</sub>\x20and\x20Fy<sub>b</sub>\x20and\x20function\x20as\x20receptors\x20for\x20<strong>Plasmodium\x20vivax</strong>.\x20The\x20Duffy\x20negative\x20phenotype\x20is\x20common\x20in\x20Africans\x20and\x20provides\x20resistance\x20to\x20Plasmodium\x20vivax.</li>\x0a<li>Other\x20blood\x20group\x20systems\x20include\x20the\x20<strong>Kidd\x20system\x20</strong>with\x20antigens\x20coded\x20by\x20genes\x20located\x20on\x20chromosome\x2018\x20and\x20<strong>MNS\x20system</strong>\x20with\x2049\x20antigens\x20coded\x20by\x20genes\x20on\x20chromosome\x204.</li>\x0a</ul>','correct_choice_id':0x97,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x554b79(0x40e)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x11,'choices':[{'id':0xa1,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A</span></p>'},{'id':0xa2,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>B</span></p>'},{'id':0xa3,'text':_0x554b79(0x437)},{'id':0xa4,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>None</span></p>'}],'text':_0x554b79(0x436),'unique_key':_0x554b79(0x406),'question_audio':null,'question_video':null,'map_id':0x12317e,'difficulty_level':_0x554b79(0x2dd),'subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p><strong>Blood\x20group\x20O</strong>\x20is\x20more\x20prone\x20to\x20<strong>Helicobacter\x20pylori\x20infections</strong>.</p>\x0a<ul>\x0a<li>Erythrocyte\x20blood\x20groups\x20are\x20defined\x20by\x20specific\x20<strong>antigenic\x20molecules</strong>\x20present\x20on\x20the\x20surface\x20of\x20red\x20blood\x20cells\x20and\x20other\x20cells.\x20These\x20antigens\x20are\x20inherited\x20and\x20recognized\x20by\x20corresponding\x20antibodies.</li>\x0a<li>Their\x20variability\x20has\x20clinical\x20significance\x20in<strong>\x20transfusion</strong>,\x20pregnancy,\x20and\x20transplantation\x20due\x20to\x20the\x20risk\x20of\x20immune\x20reactions.</li>\x0a<li>The\x20diversity\x20of\x20blood\x20group\x20antigens\x20also\x20relates\x20to\x20environmental\x20and\x20pathogen\x20interactions,\x20influencing\x20<strong>disease\x20susceptibility</strong>.\x20For\x20instance,\x20individuals\x20with\x20blood\x20group\x20O\x20are\x20more\x20prone\x20to\x20Helicobacter\x20pylori\x20infection.</li>\x0a<li><strong>Malaria</strong>\x20tends\x20to\x20be\x20less\x20severe\x20in\x20individuals\x20with\x20blood\x20group\x20O\x20compared\x20to\x20those\x20with\x20non-O\x20blood\x20groups.</li>\x0a</ul>','correct_choice_id':0xa3,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x554b79(0x49e),'tags':[_0x554b79(0x40e)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x12,'choices':[{'id':0xab,'text':_0x554b79(0x2eb)},{'id':0xac,'text':_0x554b79(0x4a9)},{'id':0xad,'text':_0x554b79(0x32e)},{'id':0xae,'text':_0x554b79(0x414)}],'text':_0x554b79(0x1eb),'unique_key':'DT1192320','question_audio':null,'question_video':null,'map_id':0x123180,'difficulty_level':_0x554b79(0x2dd),'subjects_id':[0x1],'solution':_0x554b79(0x242),'correct_choice_id':0xab,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x554b79(0x49e),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x13,'choices':[{'id':0xb5,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>T\x20cell</span></p>'},{'id':0xb6,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>B\x20cell</span></p>'},{'id':0xb7,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Dendritic\x20cell</span></p>'},{'id':0xb8,'text':_0x554b79(0x252)}],'text':_0x554b79(0x2cd),'unique_key':_0x554b79(0x3a8),'question_audio':null,'question_video':null,'map_id':0x123183,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x554b79(0x41a),'correct_choice_id':0xb7,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x554b79(0x49e),'tags':[_0x554b79(0x40e)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x14,'choices':[{'id':0xbf,'text':_0x554b79(0x258)},{'id':0xc0,'text':_0x554b79(0x398)},{'id':0xc1,'text':_0x554b79(0x240)},{'id':0xc2,'text':_0x554b79(0x494)}],'text':_0x554b79(0x36c),'unique_key':'DT1192325','question_audio':null,'question_video':null,'map_id':0x123185,'difficulty_level':_0x554b79(0x2dd),'subjects_id':[0x1],'solution':_0x554b79(0x2ab),'correct_choice_id':0xc1,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x554b79(0x40e)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x15,'choices':[{'id':0xc9,'text':_0x554b79(0x28a)},{'id':0xca,'text':_0x554b79(0x2ad)},{'id':0xcb,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Cytogenetic\x20clonal\x20evolution</span></p>'},{'id':0xcc,'text':_0x554b79(0x47c)}],'text':_0x554b79(0x427),'unique_key':_0x554b79(0x333),'question_audio':null,'question_video':null,'map_id':0x123188,'difficulty_level':_0x554b79(0x2dd),'subjects_id':[0x1],'solution':_0x554b79(0x235),'correct_choice_id':0xcc,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x554b79(0x49e),'tags':[_0x554b79(0x40e)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x16,'choices':[{'id':0xd3,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Nilotinib</span></p>'},{'id':0xd4,'text':_0x554b79(0x491)},{'id':0xd5,'text':_0x554b79(0x31d)},{'id':0xd6,'text':_0x554b79(0x42c)}],'text':_0x554b79(0x35f),'unique_key':_0x554b79(0x450),'question_audio':null,'question_video':null,'map_id':0x12318c,'difficulty_level':_0x554b79(0x2dd),'subjects_id':[0x1],'solution':_0x554b79(0x22e),'correct_choice_id':0xd4,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x554b79(0x49e),'tags':[_0x554b79(0x40e)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x17,'choices':[{'id':0xdd,'text':_0x554b79(0x29b)},{'id':0xde,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Inj\x20Cytarabine\x20(100-200mg/m2)\x20+\x20Inj\x20Daunorubicin\x20(60-90\x20mg/m2)\x20[3+7\x20regimen]</span></p>'},{'id':0xdf,'text':_0x554b79(0x47e)},{'id':0xe0,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Inj\x20Cytarabine\x20(100-200mg/m2)\x20+\x20Inj\x20Daunorubicin\x20(45\x20mg/m2)\x20[3+7\x20regimen]</span></p>'}],'text':_0x554b79(0x319),'unique_key':_0x554b79(0x3fb),'question_audio':null,'question_video':null,'map_id':0x123194,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p>Treatment\x20of\x20choice\x20in\x20young\x20patients\x20with\x20AML\x20is\x20Inj\x20Cytarabine\x20(100-200mg/m2)\x20+\x20Inj\x20Daunorubicin\x20(60-90\x20mg/m2)\x20[7+3\x20regimen]</p>\x0a<ul>\x0a<li>The\x20treatment\x20for\x20acute\x20myeloid\x20leukemia\x20(AML)\x20is\x20divided\x20into\x20two\x20phases:\x20induction\x20and\x20postremission\x20management\x20(consolidation).</li>\x0a<li>The\x20initial\x20goal\x20is\x20to\x20induce\x20complete\x20remission.\x20The\x20regimen\x20most\x20commonly\x20used\x20in\x20<strong>younger\x20patients</strong>\x20is:\x20<strong>Cytarabine</strong>\x20(S-phase\x20specific\x20antimetabolite)\x20at\x20standard\x20dose\x20(100-200\x20mg/m<sup>2</sup>)\x20administered\x20as\x20a\x20continuous\x20<strong>intravenous\x20infusion\x20for\x207\x20days</strong>.</li>\x0a<li>Along\x20with\x20it\x20<strong>anthracycline\x20therapy</strong>(DNA\x20intercalator),\x20which\x20generally\x20consists\x20of\x20<strong>daunorubicin</strong>\x20(60-90\x20mg/m<sup>2</sup>)\x20<strong>or\x20idarubicin</strong>\x20(12\x20mg/m<sup>2</sup>)\x20<strong>intravenously\x20on\x20days\x201,\x202,\x20and\x203</strong>\x20(<strong>the\x207\x20and\x203\x20regimen</strong>).</li>\x0a<li>With\x20the\x207\x20and\x203\x20regimen,\x20it\x20has\x20been\x20established\x20that\x2045\x20mg/m<sup>2</sup>dosing\x20of\x20daunorubicin\x20results\x20in\x20inferior\x20outcomes.</li>\x0a<li><strong>Older\x20patients</strong>,\x20especially\x20those\x20&gt;65\x20years\x20or\x20with\x20adverse\x20risk\x20disease,\x20or\x20those\x20who\x20are\x20unfit\x20for\x20intensive\x20anthracycline\x20+\x20cytarabine\x20regimens,\x20may\x20be\x20considered\x20for\x20<strong>investigational\x20therapy</strong>alone\x20or\x20in\x20combination\x20with\x20<strong>lower\x20intensity\x20chemotherapy</strong>\x20(azacitidine,\x20decitabine,\x20cytarabine),\x20or\x20lower\x20intensity\x20chemotherapy\x20in\x20combination\x20with\x20venetoclax.</li>\x0a</ul>','correct_choice_id':0xdd,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x554b79(0x49e),'tags':[_0x554b79(0x40e)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x18,'choices':[{'id':0xe7,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Autosomal\x20recessive</span></p>'},{'id':0xe8,'text':_0x554b79(0x2d9)},{'id':0xe9,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Both\x20A\x20and\x20B</span></p>'},{'id':0xea,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>None</span></p>'}],'text':_0x554b79(0x2a8),'unique_key':'DT1198031','question_audio':null,'question_video':null,'map_id':0x1247cf,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x554b79(0x4c7),'correct_choice_id':0xe9,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x554b79(0x49e),'tags':[_0x554b79(0x40e)],'explanation_video':null,'question_images':[],'explanation_images':[]}],quizName=_0x554b79(0x445);const quizFilename=_0x554b79(0x291);let hierarchy=[_0x554b79(0x343),'qBank',_0x554b79(0x276)];if(window[_0x554b79(0x237)]['pathname'][_0x554b79(0x25d)](_0x554b79(0x30c))){const customData=JSON[_0x554b79(0x262)](localStorage[_0x554b79(0x38b)]('customQuizData'));if(customData){const yxqEpl='5|3|2|0|1|4'[_0x554b79(0x374)]('|');let GqZnHy=0x0;while(!![]){switch(yxqEpl[GqZnHy++]){case'0':document[_0x554b79(0x44f)]=quizName+_0x554b79(0x421);continue;case'1':document[_0x554b79(0x26c)](_0x554b79(0x239))[_0x554b79(0x37a)]=questionsData['length'];continue;case'2':hierarchy=customData[_0x554b79(0x3cd)];continue;case'3':quizName=customData[_0x554b79(0x479)];continue;case'4':document['getElementById'](_0x554b79(0x3ee))['textContent']=hierarchy[_0x554b79(0x316)]('\x20>\x20');continue;case'5':questionsData=customData[_0x554b79(0x3e3)];continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x554b79(0x2d8),timer=null,timeRemaining=0x0,questionStartTime=Date[_0x554b79(0x357)](),quizStartTime=Date[_0x554b79(0x357)](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x554b79(0x4bf)])[_0x554b79(0x481)](null)[_0x554b79(0x243)](()=>({'status':_0x554b79(0x293),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData['length']};function saveProgress(){const _0x259581=_0x554b79,_0x23ae97={'dAgHh':_0x259581(0x3d9),'wxIdy':_0x259581(0x210)};if(isQuizCompleted)return;const _0x1c9957=JSON[_0x259581(0x262)](localStorage['getItem'](_0x23ae97[_0x259581(0x2a4)]))||{};_0x1c9957[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x23ae97[_0x259581(0x2f4)],'lastSeen':new Date()['toISOString']()},localStorage[_0x259581(0x49c)](_0x23ae97[_0x259581(0x2a4)],JSON['stringify'](_0x1c9957));}function loadProgress(){const _0x30b27f=_0x554b79,_0x363302={'DaiDs':_0x30b27f(0x3ea),'mcSeB':_0x30b27f(0x3d9),'pdcUw':'LPtUX','zhnIJ':_0x30b27f(0x464),'oCXbO':_0x30b27f(0x35a)},_0x43def4=JSON[_0x30b27f(0x262)](localStorage['getItem'](_0x363302[_0x30b27f(0x20c)]))||{},_0x4ee266=_0x43def4[quizFilename];if(_0x4ee266){if(_0x30b27f(0x207)===_0x363302['pdcUw']){const _0xa36d4a=_0x363302[_0x30b27f(0x306)]['split']('|');let _0xefbdfa=0x0;while(!![]){switch(_0xa36d4a[_0xefbdfa++]){case'0':currentQuestionIndex=_0x4ee266[_0x30b27f(0x40a)];continue;case'1':console[_0x30b27f(0x425)](_0x363302[_0x30b27f(0x3e0)]);continue;case'2':return!![];case'3':questionStates=_0x4ee266[_0x30b27f(0x3e8)];continue;case'4':stats=_0x4ee266[_0x30b27f(0x2b8)];continue;case'5':currentMode=_0x4ee266[_0x30b27f(0x3d7)];continue;}break;}}else _0x54eaca=_0x363302['DaiDs'];}return![];}function clearProgress(){const _0x37a88d=_0x554b79,_0x34dc8d={'HdfsE':_0x37a88d(0x3d9),'eITUn':_0x37a88d(0x321)},_0x363ee3=JSON[_0x37a88d(0x262)](localStorage[_0x37a88d(0x38b)](_0x34dc8d[_0x37a88d(0x360)]))||{};_0x363ee3[quizFilename]&&(delete _0x363ee3[quizFilename],localStorage['setItem'](_0x34dc8d[_0x37a88d(0x360)],JSON['stringify'](_0x363ee3)),console[_0x37a88d(0x425)](_0x34dc8d[_0x37a88d(0x386)]));}function markQuizAsCompleted(){const _0x53999a=_0x554b79,_0x2aa13d={'HEGBY':_0x53999a(0x3d9),'vsbqK':_0x53999a(0x33a)},_0x745775=JSON['parse'](localStorage[_0x53999a(0x38b)](_0x2aa13d[_0x53999a(0x411)]))||{},_0x3be264=questionsData[_0x53999a(0x4bf)],_0x43d8e7=stats['correctAnswers']||0x0;_0x745775[quizFilename]={'score':_0x43d8e7,'total':_0x3be264,'status':_0x2aa13d[_0x53999a(0x3c9)],'completedOn':new Date()[_0x53999a(0x220)]()},localStorage[_0x53999a(0x49c)](_0x2aa13d[_0x53999a(0x411)],JSON[_0x53999a(0x3b4)](_0x745775));}const urlParams=new URLSearchParams(window['location']['search']),startAt=parseInt(urlParams[_0x554b79(0x2ec)](_0x554b79(0x253))),resume=urlParams[_0x554b79(0x2ec)](_0x554b79(0x497))==='true';function goBack(){const _0x2c16cf=_0x554b79,_0x1bb2f0={'nxkVX':function(_0x51f56e){return _0x51f56e();},'WBEjf':_0x2c16cf(0x4b7)};if(!isQuizCompleted)_0x1bb2f0[_0x2c16cf(0x36e)](saveProgress);window[_0x2c16cf(0x237)][_0x2c16cf(0x38d)]=document[_0x2c16cf(0x312)]||_0x1bb2f0[_0x2c16cf(0x275)];}function selectMode(_0x5e2b0c){const _0x5d5cae=_0x554b79,_0x160461={'VFSdF':_0x5d5cae(0x46e),'AGejX':function(_0x488fcd){return _0x488fcd();}};currentMode=_0x5e2b0c,document[_0x5d5cae(0x26c)](_0x160461[_0x5d5cae(0x393)])['style'][_0x5d5cae(0x34e)]=_0x5d5cae(0x2df),_0x160461[_0x5d5cae(0x4ba)](initializeQuiz);}function initializeQuiz(){const _0x5d925e=_0x554b79,_0x712c94={'SSSkH':_0x5d925e(0x210),'tNpeq':_0x5d925e(0x3d9),'ziRpQ':_0x5d925e(0x23e),'YbfyE':_0x5d925e(0x4a1),'KxtAf':_0x5d925e(0x212),'dpBSO':function(_0x458429,_0x2104af){return _0x458429===_0x2104af;},'UoxEy':'test','gUzJz':'timed_exam','kEPgx':_0x5d925e(0x2a0),'IgzmK':_0x5d925e(0x2df),'rDTBD':_0x5d925e(0x3dd),'IifFi':_0x5d925e(0x469),'tCIOI':'testModeLegend','OzZGW':'submitSection','LtBTr':_0x5d925e(0x476),'vpqGy':'timed_study','dlRwK':'timerContainer','tFJmV':_0x5d925e(0x2f3),'RPVyA':function(_0x470947,_0x532499){return _0x470947(_0x532499);},'eyBNh':function(_0x1e9788,_0x15a4be){return _0x1e9788>=_0x15a4be;},'YZbIm':function(_0x1332f7,_0x556816){return _0x1332f7<_0x556816;},'GpJea':function(_0x82c15a,_0x4edd36){return _0x82c15a!==_0x4edd36;},'CJvQX':_0x5d925e(0x3c5),'MvFXY':_0x5d925e(0x441),'aSZLP':function(_0x398561){return _0x398561();},'cRShd':function(_0x1ba5aa){return _0x1ba5aa();},'xxNyD':function(_0x2231ac){return _0x2231ac();}};quizStartTime=Date[_0x5d925e(0x357)]();const _0x98ce9e=document[_0x5d925e(0x26c)](_0x712c94[_0x5d925e(0x277)]),_0x4e4693=document[_0x5d925e(0x26c)](_0x712c94[_0x5d925e(0x24b)]),_0xcf67bd=document[_0x5d925e(0x26c)](_0x712c94[_0x5d925e(0x381)]),_0x7fac42=_0x712c94[_0x5d925e(0x40d)](currentMode,_0x712c94['UoxEy'])||_0x712c94[_0x5d925e(0x40d)](currentMode,_0x712c94['gUzJz']);document['getElementById'](_0x712c94[_0x5d925e(0x2b4)])[_0x5d925e(0x28f)][_0x5d925e(0x34e)]=_0x7fac42?_0x712c94['IgzmK']:_0x712c94['rDTBD'],document[_0x5d925e(0x26c)](_0x712c94[_0x5d925e(0x226)])[_0x5d925e(0x28f)][_0x5d925e(0x34e)]=_0x7fac42?_0x712c94[_0x5d925e(0x307)]:_0x712c94['rDTBD'],document[_0x5d925e(0x26c)](_0x712c94[_0x5d925e(0x2bc)])[_0x5d925e(0x28f)]['display']=_0x7fac42?_0x712c94[_0x5d925e(0x392)]:_0x712c94[_0x5d925e(0x307)],document[_0x5d925e(0x26c)](_0x712c94[_0x5d925e(0x376)])[_0x5d925e(0x28f)][_0x5d925e(0x34e)]=_0x7fac42?_0x712c94[_0x5d925e(0x392)]:_0x712c94[_0x5d925e(0x307)],_0x98ce9e[_0x5d925e(0x28f)][_0x5d925e(0x34e)]=_0x7fac42?_0x712c94['IgzmK']:_0x712c94['LtBTr'],_0x4e4693['style']['display']=_0x7fac42?_0x5d925e(0x476):_0x712c94[_0x5d925e(0x307)],_0xcf67bd['style']['display']=_0x7fac42?_0x712c94[_0x5d925e(0x264)]:_0x712c94[_0x5d925e(0x307)];(_0x712c94[_0x5d925e(0x40d)](currentMode,_0x712c94[_0x5d925e(0x25e)])||_0x712c94[_0x5d925e(0x40d)](currentMode,_0x712c94[_0x5d925e(0x31c)]))&&document[_0x5d925e(0x26c)](_0x712c94[_0x5d925e(0x3e1)])['classList']['remove'](_0x712c94[_0x5d925e(0x1ec)]);if(!_0x712c94[_0x5d925e(0x388)](isNaN,startAt)&&_0x712c94[_0x5d925e(0x283)](startAt,0x0)&&_0x712c94['YZbIm'](startAt,questionsData['length'])){if(_0x712c94[_0x5d925e(0x498)](_0x712c94[_0x5d925e(0x348)],_0x712c94['MvFXY']))currentQuestionIndex=startAt;else{if(_0xc1cb59)return;const _0x338aa5=_0x5e0c02['parse'](_0x40fc8c[_0x5d925e(0x38b)](_0x5d925e(0x3d9)))||{};_0x338aa5[_0x5c480d]={'questionStates':_0x52fa75,'stats':_0x547db4,'currentQuestionIndex':_0xfede1d,'currentMode':_0x304db1,'status':_0x712c94[_0x5d925e(0x3f3)],'lastSeen':new _0x3e9b26()['toISOString']()},_0x5c024c[_0x5d925e(0x49c)](_0x712c94['tNpeq'],_0x57d1ec[_0x5d925e(0x3b4)](_0x338aa5));}}_0x712c94[_0x5d925e(0x416)](loadBookmarkedQuestions),generateQuestionNav(),_0x712c94[_0x5d925e(0x3cc)](updateStats),_0x712c94[_0x5d925e(0x493)](displayQuestion);}function generateQuestionNav(){const _0x52b590=_0x554b79,_0x2de17f={'WHvGn':'questionNav','Krhii':function(_0x1ffbff,_0x235631){return _0x1ffbff<_0x235631;},'JuHRT':'button','swCFn':function(_0x5034d3,_0x3aa3b1){return _0x5034d3+_0x3aa3b1;},'YnOhp':'w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200'},_0x26580f=document[_0x52b590(0x26c)](_0x2de17f[_0x52b590(0x33c)]);_0x26580f['innerHTML']='';for(let _0x1c1f5e=0x0;_0x2de17f['Krhii'](_0x1c1f5e,questionsData[_0x52b590(0x4bf)]);_0x1c1f5e++){const _0x254669=document['createElement'](_0x2de17f[_0x52b590(0x362)]);_0x254669[_0x52b590(0x37a)]=_0x2de17f['swCFn'](_0x1c1f5e,0x1),_0x254669['className']=_0x2de17f['YnOhp'],_0x254669['onclick']=()=>jumpToQuestion(_0x1c1f5e),_0x254669['id']=_0x52b590(0x49f)+_0x1c1f5e,_0x26580f[_0x52b590(0x3ef)](_0x254669);}updateQuestionNav();}function updateQuestionNav(){const _0x62351b=_0x554b79,_0x1990b1={'hmNWE':function(_0x3a5854,_0x44ad31){return _0x3a5854(_0x44ad31);},'JKfaF':'You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','IJHWe':function(_0x1703a8){return _0x1703a8();},'VpJjX':function(_0x11e66a,_0x3a9f44){return _0x11e66a===_0x3a9f44;},'uhZmc':_0x62351b(0x29e),'sBvwK':function(_0x2f4252,_0x2af3ba){return _0x2f4252+_0x2af3ba;},'ZSpbF':'Option\x20','xMLLx':'.option-button','VuOij':_0x62351b(0x2b2),'tQzoJ':_0x62351b(0x305),'Jtvjz':_0x62351b(0x202),'HhNRc':function(_0x4f8d6b,_0x35da4f){return _0x4f8d6b===_0x35da4f;},'LKnbo':'nav-btn-current','Qlhpv':function(_0x323610,_0x4266c6){return _0x323610!==_0x4266c6;},'LSlzp':'eBpDs','tykCA':'ZfJDY','YakMg':'nav-btn-marked-review','KMpdh':_0x62351b(0x208),'ambRN':_0x62351b(0x2bf),'jTReD':_0x62351b(0x20f),'nZObm':function(_0x219f3c,_0x823324){return _0x219f3c===_0x823324;},'FIXWd':_0x62351b(0x2a5),'BEScp':function(_0x2feb57,_0x1e995e){return _0x2feb57!==_0x1e995e;},'DEiMe':_0x62351b(0x21d)};for(let _0x3e64dc=0x0;_0x3e64dc<questionsData[_0x62351b(0x4bf)];_0x3e64dc++){const _0x52557f=document[_0x62351b(0x26c)](_0x62351b(0x49f)+_0x3e64dc),_0x3117ca=questionStates[_0x3e64dc];let _0x1827a3='';if(_0x1990b1['HhNRc'](_0x3e64dc,currentQuestionIndex))'YLqWG'!=='DRPAE'?_0x1827a3=_0x1990b1[_0x62351b(0x359)]:_0x1990b1['hmNWE'](_0x503111,_0x1990b1[_0x62351b(0x206)])&&(_0x4dbae3=0x0,_0xcfb6a(),_0x1990b1['IJHWe'](_0x1cc1a4));else{if(_0x3117ca[_0x62351b(0x369)]){if(_0x1990b1['Qlhpv'](_0x1990b1[_0x62351b(0x2e5)],_0x1990b1[_0x62351b(0x47a)]))_0x1827a3=_0x62351b(0x3ea);else{const _0x443d3e={'pfwdz':_0x1990b1[_0x62351b(0x2e7)],'tTttV':_0x1990b1[_0x62351b(0x286)],'ZoUIv':function(_0x3e5dd0,_0x5bb6a9){return _0x3e5dd0(_0x5bb6a9);}};_0x4a6f81[_0x62351b(0x20e)]['forEach']((_0x3063d8,_0x775b87)=>{const _0x136f7d=_0x62351b,_0x8b2c35=_0x58fa5c[_0x136f7d(0x209)](0x41+_0x775b87),_0x3fd7a2=_0x1990b1[_0x136f7d(0x4b6)](_0x49c360,_0x775b87),_0x24e328=_0x7412b3[_0x136f7d(0x4b4)](_0x136f7d(0x382));_0x24e328[_0x136f7d(0x42f)]=_0x136f7d(0x266)+(_0x3fd7a2?_0x1990b1['uhZmc']:'')+_0x136f7d(0x3c4)+_0x775b87+_0x136f7d(0x385)+_0x8b2c35+_0x136f7d(0x24a)+(_0x3063d8[_0x136f7d(0x326)]||_0x1990b1[_0x136f7d(0x2ba)](_0x1990b1[_0x136f7d(0x29d)],_0x775b87+0x1))+_0x136f7d(0x370),_0x385fff[_0x136f7d(0x3ef)](_0x24e328);}),_0x340a78[_0x62351b(0x4bc)](_0x1990b1[_0x62351b(0x2e9)],function(_0x41774f){const _0x3fcee7=_0x62351b,_0x37398f=_0x41774f[_0x3fcee7(0x4a5)]['closest'](_0x443d3e['pfwdz']);if(_0x37398f){const _0x37c709=_0x353949(_0x37398f['getAttribute'](_0x443d3e[_0x3fcee7(0x35b)]));_0x443d3e[_0x3fcee7(0x3e2)](_0x5751bf,_0x37c709);}});}}else{if(_0x3117ca[_0x62351b(0x38a)])_0x1827a3=_0x1990b1[_0x62351b(0x318)];else{if(currentMode===_0x62351b(0x2d8)||_0x1990b1[_0x62351b(0x3b0)](currentMode,_0x62351b(0x1fd))){if(_0x1990b1[_0x62351b(0x3b0)](_0x1990b1[_0x62351b(0x287)],_0x1990b1[_0x62351b(0x287)])){if(_0x1990b1['VpJjX'](_0x3117ca[_0x62351b(0x234)],_0x1990b1[_0x62351b(0x323)]))_0x1827a3=_0x1990b1[_0x62351b(0x4a6)];else{if(_0x1990b1['nZObm'](_0x3117ca[_0x62351b(0x234)],_0x1990b1[_0x62351b(0x487)]))_0x1827a3='nav-btn-incorrect';else _0x1827a3=_0x62351b(0x21d);}}else{const _0x25e195=!_0x14653f[_0x483d33][_0x62351b(0x369)];_0xa37cab[_0x2d2031][_0x62351b(0x369)]=_0x25e195;let _0x3ede6d=_0xc34fe8[_0x62351b(0x262)](_0x7aa8b9['getItem'](_0x1990b1[_0x62351b(0x301)]))||[];if(_0x25e195){const _0x3761d6={'quizName':_0x306ce4,'quizFile':_0x38e259[_0x62351b(0x237)][_0x62351b(0x4ae)][_0x62351b(0x374)]('/')[_0x62351b(0x2d4)](),'questionIndex':_0x14ebb3,'question':_0x48ea13[_0x263968],'hierarchy':_0x49b5ae,'timestamp':_0x20a692[_0x62351b(0x357)]()};_0x3ede6d[_0x62351b(0x46b)](_0x3761d6);}else _0x3ede6d=_0x3ede6d[_0x62351b(0x347)](_0x2e8a65=>!(_0x2e8a65[_0x62351b(0x42e)][_0x62351b(0x355)](_0x1bbcb9['toLowerCase']()['replace'](/ /g,'-'))&&_0x2e8a65[_0x62351b(0x342)]===_0xcf6107));_0x2a13da['setItem'](_0x62351b(0x202),_0x130bb7['stringify'](_0x3ede6d)),_0x1990b1[_0x62351b(0x409)](_0x22b8e4),_0x1990b1['IJHWe'](_0x17bc38);}}else{if(_0x1990b1[_0x62351b(0x3be)](_0x3117ca[_0x62351b(0x4ca)],null))_0x1827a3=_0x62351b(0x399);else _0x1827a3=_0x1990b1['DEiMe'];}}}}_0x52557f[_0x62351b(0x3ff)]='w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20'+_0x1827a3;}}function jumpToQuestion(_0x3ebb30){const _0xb39fb1=_0x554b79,_0x3a71c4={'FbUTA':function(_0x3f6803,_0x10e420){return _0x3f6803>=_0x10e420;},'dCnIU':function(_0x3c173b,_0x509637){return _0x3c173b-_0x509637;},'Dqfdl':function(_0x1a1961){return _0x1a1961();}};_0x3a71c4[_0xb39fb1(0x463)](_0x3ebb30,0x0)&&_0x3ebb30<questionsData[_0xb39fb1(0x4bf)]&&(questionStartTime&&(questionStates[currentQuestionIndex]['timeSpent']+=_0x3a71c4[_0xb39fb1(0x32b)](Date[_0xb39fb1(0x357)](),questionStartTime)),currentQuestionIndex=_0x3ebb30,_0x3a71c4[_0xb39fb1(0x273)](displayQuestion),saveProgress());}function updateStats(){const _0x38bdfa=_0x554b79,_0x16ba90={'YWlrA':function(_0x31628a,_0x14ffb1){return _0x31628a===_0x14ffb1;},'sCuKr':_0x38bdfa(0x324),'ohygk':_0x38bdfa(0x418),'pAhyk':_0x38bdfa(0x247),'DNzwR':function(_0x3a4406,_0x1ad914){return _0x3a4406>_0x1ad914;},'ItCnK':function(_0x5a02a0,_0x3d5212){return _0x5a02a0*_0x3d5212;},'TcVTx':function(_0x1f95a2,_0x416c05){return _0x1f95a2/_0x416c05;},'ERDTG':_0x38bdfa(0x2ea),'iVTsO':function(_0x3c2136,_0x3f7bb4){return _0x3c2136+_0x3f7bb4;},'GtaMB':function(_0x1c8e57,_0x3e6a67){return _0x1c8e57/_0x3e6a67;},'ODcKA':function(_0x5d67ea,_0x4653e2){return _0x5d67ea/_0x4653e2;},'glfQz':function(_0x1be8c2,_0x386a84){return _0x1be8c2%_0x386a84;},'mzqUJ':_0x38bdfa(0x284)};if(_0x16ba90[_0x38bdfa(0x433)](currentMode,_0x38bdfa(0x2d8))||_0x16ba90[_0x38bdfa(0x433)](currentMode,'timed_study')){document[_0x38bdfa(0x26c)](_0x16ba90[_0x38bdfa(0x33d)])[_0x38bdfa(0x37a)]=stats['correctAnswers'],document[_0x38bdfa(0x26c)](_0x16ba90[_0x38bdfa(0x368)])[_0x38bdfa(0x37a)]=stats[_0x38bdfa(0x271)],document[_0x38bdfa(0x26c)](_0x16ba90[_0x38bdfa(0x461)])[_0x38bdfa(0x37a)]=stats[_0x38bdfa(0x247)];const _0x30ae20=_0x16ba90[_0x38bdfa(0x265)](stats[_0x38bdfa(0x247)],0x0)?Math['round'](_0x16ba90['ItCnK'](_0x16ba90[_0x38bdfa(0x28c)](stats[_0x38bdfa(0x25f)],stats['totalAttempted']),0x64)):0x0;document[_0x38bdfa(0x26c)](_0x16ba90['ERDTG'])[_0x38bdfa(0x37a)]=_0x16ba90[_0x38bdfa(0x249)](_0x30ae20,'%'),stats['totalTime']=questionStates[_0x38bdfa(0x4c8)]((_0x23aaeb,_0x39e7a7)=>_0x23aaeb+_0x39e7a7['timeSpent'],0x0);const _0x52b9dd=Math[_0x38bdfa(0x270)](_0x16ba90[_0x38bdfa(0x31e)](stats[_0x38bdfa(0x400)],0x3e8)),_0x3809c7=Math[_0x38bdfa(0x270)](_0x16ba90[_0x38bdfa(0x2a7)](_0x52b9dd,0x3c)),_0x4d5c66=_0x16ba90['glfQz'](_0x52b9dd,0x3c);document['getElementById'](_0x16ba90['mzqUJ'])[_0x38bdfa(0x37a)]=_0x16ba90['iVTsO'](_0x3809c7,':')+_0x4d5c66['toString']()[_0x38bdfa(0x31f)](0x2,'0');}}function setupVideo(_0x56b2f0,_0x1c1272){const _0x5ec6a9=_0x554b79,_0x2031df={'mMuAC':function(_0x40438e,_0xe09abc){return _0x40438e===_0xe09abc;},'DwttO':'application/vnd.apple.mpegurl'};if(Hls['isSupported']()){if(_0x2031df[_0x5ec6a9(0x380)](_0x5ec6a9(0x2ce),_0x5ec6a9(0x462)))_0x51d813[_0x104927][_0x5ec6a9(0x234)]=_0x5ec6a9(0x320),_0x15fb21[_0x5ec6a9(0x247)]++,_0x2251c4[_0x5ec6a9(0x40f)]--;else{const _0x5f0890=new Hls();_0x5f0890[_0x5ec6a9(0x298)](_0x1c1272),_0x5f0890[_0x5ec6a9(0x2ee)](_0x56b2f0);}}else _0x56b2f0[_0x5ec6a9(0x3f5)](_0x2031df['DwttO'])&&(_0x56b2f0['src']=_0x1c1272);}function displayQuestion(){const _0x394133=_0x554b79,_0x1260a1={'rBHsH':function(_0x1ced48,_0x51c929){return _0x1ced48===_0x51c929;},'VrgzJ':_0x394133(0x29e),'Nptig':function(_0x5391b2,_0x16e341){return _0x5391b2+_0x16e341;},'STEDl':_0x394133(0x352),'yboMp':'correct','JWhDi':_0x394133(0x2a5),'QGjHW':_0x394133(0x227),'WnOUz':'sdXgr','Mttbv':function(_0x36dc42,_0x25056b){return _0x36dc42(_0x25056b);},'TmiyT':'VblEP','MjjeO':_0x394133(0x2cb),'BbAfb':_0x394133(0x24f),'gXZnK':_0x394133(0x3cf),'BmluU':function(_0x3c50a9,_0xc980b1){return _0x3c50a9+_0xc980b1;},'lPuTN':_0x394133(0x473),'kwfJw':_0x394133(0x465),'uyyjA':function(_0x46d7de,_0x40ceaf){return _0x46d7de+_0x40ceaf;},'PNxNW':function(_0x20dc28){return _0x20dc28();},'BIZJO':_0x394133(0x403),'pfKYU':'solutionContainer','KIVDc':'hidden','czJHK':_0x394133(0x269),'yhHOC':'questionMedia','NwRDc':_0x394133(0x320),'NGELF':function(_0x4fd88e,_0xc62c36){return _0x4fd88e===_0xc62c36;},'zphZh':_0x394133(0x3d6),'jsrLT':'click','VuwXg':_0x394133(0x1fd),'ZQfgK':function(_0x19b719,_0x9cabb0){return _0x19b719===_0x9cabb0;},'rmkqn':_0x394133(0x408),'fCgwT':function(_0x108ede,_0x3abc67){return _0x108ede!==_0x3abc67;},'ZGuye':'TBkax'};if(!questionsData||questionsData[_0x394133(0x4bf)]===0x0){if(_0x1260a1[_0x394133(0x378)]!==_0x1260a1[_0x394133(0x444)]){document[_0x394133(0x26c)](_0x1260a1[_0x394133(0x36b)])['innerHTML']=_0x1260a1[_0x394133(0x364)];return;}else{const _0x5e2479=_0x22f0d6['apply'](_0x56d6a1,arguments);return _0x4b2f57=null,_0x5e2479;}};const _0x3c7f79=questionsData[currentQuestionIndex];questionStartTime=Date[_0x394133(0x357)](),selectedOption=questionStates[currentQuestionIndex][_0x394133(0x4ca)];const _0x49254f=_0x1260a1[_0x394133(0x4c1)](currentQuestionIndex,0x1)/questionsData[_0x394133(0x4bf)]*0x64;document['getElementById'](_0x1260a1['lPuTN'])[_0x394133(0x28f)][_0x394133(0x295)]=_0x1260a1[_0x394133(0x4c1)](_0x49254f,'%'),document[_0x394133(0x26c)](_0x1260a1['kwfJw'])[_0x394133(0x37a)]=_0x1260a1[_0x394133(0x383)](currentQuestionIndex,0x1),_0x1260a1[_0x394133(0x218)](updateQuestionNav),document[_0x394133(0x26c)](_0x1260a1[_0x394133(0x2ff)])['disabled']=currentQuestionIndex===0x0,document[_0x394133(0x26c)](_0x1260a1['pfKYU'])['classList']['add'](_0x1260a1[_0x394133(0x4c3)]),document[_0x394133(0x26c)](_0x1260a1[_0x394133(0x36b)])[_0x394133(0x42f)]=_0x3c7f79[_0x394133(0x326)]||_0x1260a1['czJHK'];let _0x5e8460='';if(_0x3c7f79[_0x394133(0x232)])_0x5e8460+=_0x394133(0x460)+_0x3c7f79[_0x394133(0x232)]+_0x394133(0x3bd);if(_0x3c7f79['question_video'])_0x5e8460+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22'+_0x3c7f79[_0x394133(0x201)]+_0x394133(0x2a3);_0x3c7f79[_0x394133(0x440)]&&_0x3c7f79['question_images'][_0x394133(0x442)](_0x33189c=>{const _0x4cfb24=_0x394133;if(_0x33189c)_0x5e8460+=_0x4cfb24(0x329)+_0x33189c+'\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';});document[_0x394133(0x26c)](_0x1260a1['yhHOC'])[_0x394133(0x42f)]=_0x5e8460;const _0xa53a37=document['getElementById'](_0x394133(0x29c));_0xa53a37[_0x394133(0x42f)]='',_0xa53a37[_0x394133(0x2d1)]['remove'](_0x1260a1[_0x394133(0x2ae)]);_0x3c7f79['choices']&&Array['isArray'](_0x3c7f79['choices'])&&(_0x1260a1[_0x394133(0x1fe)](_0x1260a1[_0x394133(0x310)],_0x1260a1['zphZh'])?(_0x3c7f79['choices'][_0x394133(0x442)]((_0x4e9bf7,_0x5e85f4)=>{const _0xd36ae9=_0x394133,_0x10901f=String['fromCharCode'](0x41+_0x5e85f4),_0x36ca8e=_0x1260a1[_0xd36ae9(0x238)](selectedOption,_0x5e85f4),_0x2d8bba=document[_0xd36ae9(0x4b4)](_0xd36ae9(0x382));_0x2d8bba['innerHTML']='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20'+(_0x36ca8e?_0x1260a1[_0xd36ae9(0x222)]:'')+'\x22\x20data-option-index=\x22'+_0x5e85f4+_0xd36ae9(0x385)+_0x10901f+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>'+(_0x4e9bf7[_0xd36ae9(0x326)]||_0x1260a1['Nptig'](_0x1260a1[_0xd36ae9(0x3d0)],_0x5e85f4+0x1))+_0xd36ae9(0x370),_0xa53a37['appendChild'](_0x2d8bba);}),_0xa53a37[_0x394133(0x4bc)](_0x1260a1[_0x394133(0x4c2)],function(_0x4cfccc){const _0xf1dafb=_0x394133,_0x145921=_0x4cfccc['target'][_0xf1dafb(0x2af)](_0x1260a1[_0xf1dafb(0x300)]);if(_0x145921){if(_0x1260a1[_0xf1dafb(0x3a0)]!==_0x1260a1['WnOUz'])_0x1260a1['rBHsH'](_0x624f9b['choices'][_0x3b2ac4[_0xf1dafb(0x4ca)]]['id'],_0x2f2d25[_0xf1dafb(0x281)])?(_0x3e4b65++,_0x594f85['status']=_0x1260a1[_0xf1dafb(0x492)]):(_0x139fb5++,_0x198ea0['status']=_0x1260a1[_0xf1dafb(0x26a)]);else{const _0x2f0d16=_0x1260a1[_0xf1dafb(0x34d)](parseInt,_0x145921[_0xf1dafb(0x2d7)](_0xf1dafb(0x2b2)));_0x1260a1[_0xf1dafb(0x34d)](selectOption,_0x2f0d16);}}})):_0x39455c[_0x51ab11][_0x394133(0x284)]+=_0xce4f04['now']()-_0x1dc26d);updateBookmarkButton(),_0x1260a1[_0x394133(0x218)](updateMarkReviewButton);if((currentMode===_0x1260a1[_0x394133(0x2da)]||_0x1260a1[_0x394133(0x3fd)](currentMode,_0x1260a1[_0x394133(0x366)]))&&!isQuizCompleted){if(_0x1260a1[_0x394133(0x2dc)](_0x394133(0x3ab),_0x1260a1[_0x394133(0x37b)])){const _0x480f73=_0x487985?function(){const _0x4ce88d=_0x394133;if(_0x284160){const _0x44e332=_0x115ca4[_0x4ce88d(0x2ed)](_0x400912,arguments);return _0x38f116=null,_0x44e332;}}:function(){};return _0x2d5b2f=![],_0x480f73;}else _0x1260a1[_0x394133(0x218)](startTimer);}}function selectOption(_0x418c7e){const _0x31f8d2=_0x554b79,_0x2b5a4b={'JjGLm':function(_0x80d2de,_0x4da65a){return _0x80d2de!==_0x4da65a;},'OlyFA':_0x31f8d2(0x399),'mTJsX':_0x31f8d2(0x21d),'JJUhs':'selected','LLcaI':function(_0x22daa2,_0x1de29f){return _0x22daa2===_0x1de29f;},'BFSrZ':'bookmarkBtn','QEYhd':_0x31f8d2(0x446),'sqeuq':_0x31f8d2(0x3d5),'jGzbe':_0x31f8d2(0x314),'IfZAc':'No\x20questions\x20available\x20for\x20this\x20quiz.','gHJKW':_0x31f8d2(0x320),'ACYcD':function(_0x3582c0,_0x446535){return _0x3582c0===_0x446535;},'FOkYh':_0x31f8d2(0x2e0),'ymibd':function(_0x1048d3,_0x27bf1e){return _0x1048d3-_0x27bf1e;},'JXQFW':_0x31f8d2(0x227),'foFvJ':_0x31f8d2(0x2d8),'sRSoI':_0x31f8d2(0x1fd),'QHSrq':function(_0x46167d,_0x30656f){return _0x46167d===_0x30656f;},'fTpXI':'enDRF','PNgWB':function(_0x4b0967){return _0x4b0967();},'qPOYw':function(_0x2012f4,_0x57af76){return _0x2012f4===_0x57af76;},'uKiYp':_0x31f8d2(0x1f8),'zPNYU':function(_0x188ed2){return _0x188ed2();}},_0x149174=document[_0x31f8d2(0x26c)](_0x31f8d2(0x29c));if(_0x149174[_0x31f8d2(0x2d1)][_0x31f8d2(0x223)](_0x2b5a4b[_0x31f8d2(0x1f3)]))return;if(questionStartTime){if(_0x2b5a4b['ACYcD'](_0x31f8d2(0x3da),_0x2b5a4b[_0x31f8d2(0x3f0)])){if(_0x2b5a4b[_0x31f8d2(0x22d)](_0x486995[_0x31f8d2(0x4ca)],null))_0x46751f=_0x2b5a4b[_0x31f8d2(0x2b5)];else _0x3a3f99=_0x2b5a4b['mTJsX'];}else questionStates[currentQuestionIndex][_0x31f8d2(0x284)]+=_0x2b5a4b[_0x31f8d2(0x32f)](Date[_0x31f8d2(0x357)](),questionStartTime),questionStartTime=Date[_0x31f8d2(0x357)]();}selectedOption=_0x418c7e,questionStates[currentQuestionIndex][_0x31f8d2(0x4ca)]=_0x418c7e,document['querySelectorAll'](_0x2b5a4b[_0x31f8d2(0x4b3)])[_0x31f8d2(0x442)]((_0x43a0db,_0x4b4d8c)=>{const _0x482b80=_0x31f8d2;_0x43a0db['classList']['toggle'](_0x2b5a4b[_0x482b80(0x39f)],_0x2b5a4b[_0x482b80(0x260)](_0x4b4d8c,_0x418c7e));});if(_0x2b5a4b['ACYcD'](currentMode,_0x2b5a4b['foFvJ'])||_0x2b5a4b[_0x31f8d2(0x260)](currentMode,_0x2b5a4b['sRSoI'])){if(_0x2b5a4b[_0x31f8d2(0x4c5)](_0x2b5a4b[_0x31f8d2(0x48e)],_0x2b5a4b['fTpXI']))_0x2b5a4b[_0x31f8d2(0x27d)](processAnswer);else{const _0x8b9e0f=_0x5d6b0a[_0x31f8d2(0x26c)](_0x2b5a4b[_0x31f8d2(0x255)]),_0x25388c=_0x416ad1[_0x31f8d2(0x26c)](_0x31f8d2(0x495)),_0x599746=_0x2cea21[_0x464b0c][_0x31f8d2(0x369)];_0x8b9e0f[_0x31f8d2(0x3ff)]=_0x599746?_0x2b5a4b[_0x31f8d2(0x37f)]:_0x2b5a4b[_0x31f8d2(0x394)],_0x25388c['textContent']=_0x599746?_0x2b5a4b['jGzbe']:_0x31f8d2(0x39e);}}else{if(_0x2b5a4b[_0x31f8d2(0x214)](questionStates[currentQuestionIndex][_0x31f8d2(0x234)],'not_attempted')){if(_0x31f8d2(0x2b7)===_0x2b5a4b['uKiYp']){_0x331d7c[_0x31f8d2(0x26c)]('questionText')[_0x31f8d2(0x42f)]=_0x2b5a4b[_0x31f8d2(0x402)];return;}else questionStates[currentQuestionIndex][_0x31f8d2(0x234)]=_0x2b5a4b[_0x31f8d2(0x1f3)],stats[_0x31f8d2(0x247)]++,stats['notAttempted']--;}_0x2b5a4b[_0x31f8d2(0x2f0)](updateQuestionNav);}saveProgress();}function processAnswer(){const _0x46d0bd=_0x554b79,_0x1b28d7={'rdKsR':function(_0x5357db,_0x1f8510){return _0x5357db===_0x1f8510;},'ODUZA':function(_0x16cf26,_0x42b9c3){return _0x16cf26===_0x42b9c3;},'tTcBb':_0x46d0bd(0x293),'UskAl':_0x46d0bd(0x2bf),'gyuKD':_0x46d0bd(0x2a5),'HTCYE':function(_0x4fa54e){return _0x4fa54e();}},_0xd52ae8=questionsData[currentQuestionIndex],_0x5bc0ca=_0xd52ae8[_0x46d0bd(0x281)];if(selectedOption===null)return;const _0x2c92b6=_0xd52ae8[_0x46d0bd(0x20e)][selectedOption],_0x4393df=_0x1b28d7['rdKsR'](_0x2c92b6['id'],_0x5bc0ca);if(_0x1b28d7[_0x46d0bd(0x31b)](questionStates[currentQuestionIndex][_0x46d0bd(0x234)],_0x1b28d7[_0x46d0bd(0x4a7)])){stats[_0x46d0bd(0x247)]++,stats['notAttempted']--;if(_0x4393df)stats[_0x46d0bd(0x25f)]++;else stats[_0x46d0bd(0x271)]++;}questionStates[currentQuestionIndex]['status']=_0x4393df?_0x1b28d7[_0x46d0bd(0x3fc)]:_0x1b28d7[_0x46d0bd(0x24d)],_0x1b28d7['HTCYE'](updateStats),showInlineFeedback(_0x4393df),updateQuestionNav();}function showInlineFeedback(_0x249c84){const _0x2b15eb=_0x554b79,_0x2e1ecf={'cgJtb':_0x2b15eb(0x29e),'VjKSO':'incorrect','qwphu':function(_0xbdb6e6,_0x2b8b09){return _0xbdb6e6!==_0x2b8b09;},'SxjFF':_0x2b15eb(0x2d8),'YJshL':_0x2b15eb(0x320),'AWbRb':function(_0x54d06e){return _0x54d06e();}};if(_0x2e1ecf[_0x2b15eb(0x2c7)](currentMode,_0x2e1ecf[_0x2b15eb(0x35d)])&&_0x2e1ecf[_0x2b15eb(0x2c7)](currentMode,'timed_study'))return;const _0x5914eb=document[_0x2b15eb(0x26c)]('optionsContainer'),_0x367a51=_0x5914eb[_0x2b15eb(0x443)]('.option-button'),_0x51f247=questionsData[currentQuestionIndex],_0x3b6c68=_0x51f247['correct_choice_id'];let _0x3116b5=_0x51f247[_0x2b15eb(0x20e)][_0x2b15eb(0x339)](_0x5a78f9=>_0x5a78f9['id']===_0x3b6c68);_0x5914eb[_0x2b15eb(0x2d1)]['add'](_0x2e1ecf[_0x2b15eb(0x34c)]),_0x367a51[_0x2b15eb(0x442)]((_0x477f84,_0x5cedff)=>{const _0x45cbb4=_0x2b15eb;_0x477f84['classList'][_0x45cbb4(0x358)](_0x2e1ecf[_0x45cbb4(0x47f)]);if(_0x5cedff===_0x3116b5)_0x477f84[_0x45cbb4(0x2d1)][_0x45cbb4(0x205)](_0x45cbb4(0x2bf));else{if(_0x5cedff===selectedOption&&!_0x249c84)_0x477f84[_0x45cbb4(0x2d1)]['add'](_0x2e1ecf[_0x45cbb4(0x2f2)]);}}),_0x2e1ecf[_0x2b15eb(0x30d)](showSolution);}function showSolution(){const _0xec42d1=_0x554b79,_0x42effe={'HGuGw':function(_0x53f94b){return _0x53f94b();},'ukoHz':function(_0x5d165f,_0x2ce66d){return _0x5d165f<=_0x2ce66d;},'GlJDf':function(_0x4c716e,_0x486263){return _0x4c716e(_0x486263);},'hUCqQ':function(_0x40be4d,_0x630ab4){return _0x40be4d===_0x630ab4;},'GjOaw':_0xec42d1(0x408),'GlRBV':function(_0x1912bd){return _0x1912bd();},'xduSs':'correct','edJOa':_0xec42d1(0x20f),'lXovx':function(_0x49dc38,_0xb37020){return _0x49dc38===_0xb37020;},'qxRGJ':_0xec42d1(0x2a5),'aNEVk':_0xec42d1(0x48a),'PBKwc':'nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','OwVuF':function(_0x1f014c,_0x1bddb9){return _0x1f014c!==_0x1bddb9;},'MsbcI':_0xec42d1(0x1f6),'LmMhG':_0xec42d1(0x2d8),'mrOmU':_0xec42d1(0x1fd),'QaPWH':_0xec42d1(0x30a),'CFnZD':_0xec42d1(0x2bd),'DHfVm':_0xec42d1(0x2f3),'wGnDs':_0xec42d1(0x327),'xDyTG':function(_0x5253ca,_0x5556bb,_0xcd8c0a){return _0x5253ca(_0x5556bb,_0xcd8c0a);},'apGsi':_0xec42d1(0x268),'mrXKK':_0xec42d1(0x3ad),'rWSFO':_0xec42d1(0x204)};if(_0x42effe[_0xec42d1(0x250)](currentMode,_0x42effe[_0xec42d1(0x3df)])&&currentMode!==_0x42effe['mrOmU'])return;const _0x2b2694=questionsData[currentQuestionIndex];document['getElementById'](_0x42effe[_0xec42d1(0x1ee)])[_0xec42d1(0x42f)]=_0x2b2694['solution']||_0x42effe[_0xec42d1(0x338)];const _0x483d63=document[_0xec42d1(0x26c)](_0xec42d1(0x296)),_0x361c12=document['getElementById'](_0xec42d1(0x3bf)),_0x5ecb3f=_0x2b2694[_0xec42d1(0x3b8)];if(_0x5ecb3f){_0x483d63['classList'][_0xec42d1(0x358)](_0x42effe[_0xec42d1(0x415)]);if(_0x5ecb3f[_0xec42d1(0x355)](_0x42effe['wGnDs']))_0x42effe[_0xec42d1(0x405)](setupVideo,_0x361c12,_0x5ecb3f);else _0x361c12[_0xec42d1(0x224)]=_0x5ecb3f;}else _0x42effe['OwVuF'](_0xec42d1(0x4bd),_0x42effe[_0xec42d1(0x36f)])?_0x483d63[_0xec42d1(0x2d1)]['add'](_0x42effe[_0xec42d1(0x415)]):(_0x5e0aa0--,_0x42effe[_0xec42d1(0x4b0)](_0x45a4cb),_0x42effe[_0xec42d1(0x289)](_0x5c3f95,0x0)&&(_0x42effe[_0xec42d1(0x32c)](_0xb9e3d4,_0x500902),_0x42effe[_0xec42d1(0x278)](_0x3d2fac,_0x42effe['GjOaw'])?_0x42effe[_0xec42d1(0x3e6)](_0x3cb6fd):_0x42effe[_0xec42d1(0x4b0)](_0x6ea9e0)));const _0x56211d=document[_0xec42d1(0x26c)](_0xec42d1(0x420));_0x56211d[_0xec42d1(0x42f)]='';_0x2b2694['explanation_audio_eng']&&(_0x56211d[_0xec42d1(0x42f)]+=_0xec42d1(0x1f2)+_0x2b2694[_0xec42d1(0x349)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>');_0x2b2694['explanation_audio_hin']&&(_0x56211d[_0xec42d1(0x42f)]+=_0xec42d1(0x3cb)+_0x2b2694[_0xec42d1(0x457)]+_0xec42d1(0x3bd));const _0xee5903=document[_0xec42d1(0x26c)](_0x42effe['mrXKK']);_0xee5903[_0xec42d1(0x42f)]='',_0x2b2694[_0xec42d1(0x2f9)]&&_0x2b2694['explanation_images'][_0xec42d1(0x442)](_0x228c86=>{const _0x34f19d=_0xec42d1;if(_0x42effe['OwVuF'](_0x34f19d(0x485),_0x42effe[_0x34f19d(0x3f2)])){if(_0x228c86)_0xee5903['innerHTML']+='<div\x20class=\x22mt-4\x22><img\x20src=\x22'+_0x228c86+_0x34f19d(0x33b);}else{if(_0x42effe[_0x34f19d(0x278)](_0x626fe6[_0x34f19d(0x234)],_0x42effe[_0x34f19d(0x4ab)]))_0xa915a0=_0x42effe[_0x34f19d(0x2ac)];else{if(_0x42effe[_0x34f19d(0x30b)](_0x270132[_0x34f19d(0x234)],_0x42effe[_0x34f19d(0x390)]))_0x71752b=_0x42effe[_0x34f19d(0x3b9)];else _0x474f7e=_0x42effe[_0x34f19d(0x233)];}}}),document['getElementById'](_0x42effe[_0xec42d1(0x48c)])[_0xec42d1(0x2d1)]['remove'](_0x42effe['DHfVm']);}function submitQuiz(){const _0x3838c6=_0x554b79,_0x261985={'zVgPf':function(_0x41fe03,_0x19dc3f){return _0x41fe03+_0x19dc3f;},'DbaVI':'selected','qlIwB':_0x3838c6(0x352),'GsnpL':function(_0x4142cd){return _0x4142cd();},'xgfcC':_0x3838c6(0x43c),'FSkxz':_0x3838c6(0x371),'LbQCD':function(_0x922cd3,_0x3bc202){return _0x922cd3!==_0x3bc202;},'VRivi':function(_0x437273,_0x475caf){return _0x437273!==_0x475caf;},'FUiPm':_0x3838c6(0x340),'foyIp':'fYtBr','myHju':_0x3838c6(0x334),'iIzHz':'correct','Gwtzz':function(_0x51e287,_0x4edd8f){return _0x51e287===_0x4edd8f;},'PNnjW':'bDDNw','Yesfj':'incorrect','LWRcL':function(_0x1e0fff,_0x25b2b9){return _0x1e0fff(_0x25b2b9);},'nLsMq':_0x3838c6(0x482),'gdtHj':function(_0x795b5f,_0x37adbd){return _0x795b5f-_0x37adbd;},'bVvEk':_0x3838c6(0x3a6),'WSdwe':function(_0x41447b,_0x14cf53){return _0x41447b-_0x14cf53;}};if(timer)_0x261985['LWRcL'](clearInterval,timer);if(!confirm(_0x261985[_0x3838c6(0x1f4)]))return;isQuizCompleted=!![];let _0x12ac84=0x0,_0x4d8ef1=0x0;const _0x3340e4=Date[_0x3838c6(0x357)]()-quizStartTime;questionsData[_0x3838c6(0x442)]((_0x3683fb,_0x452f7c)=>{const _0x30337d=_0x3838c6,_0x51f8fe={'trtBk':function(_0x171ccd,_0x277d51){return _0x261985['zVgPf'](_0x171ccd,_0x277d51);},'pChRq':_0x261985[_0x30337d(0x2d2)],'WzzAM':function(_0x10c4cd,_0x204d66){const _0x2fd195=_0x30337d;return _0x261985[_0x2fd195(0x37e)](_0x10c4cd,_0x204d66);},'UVqSi':_0x261985[_0x30337d(0x263)],'Qotij':function(_0x1f818d){const _0xfc3766=_0x30337d;return _0x261985[_0xfc3766(0x23a)](_0x1f818d);}};if(_0x261985['xgfcC']!==_0x261985[_0x30337d(0x2c4)]){const _0x2c4d5f=questionStates[_0x452f7c];if(_0x261985[_0x30337d(0x447)](_0x2c4d5f[_0x30337d(0x4ca)],null)){if(_0x261985[_0x30337d(0x429)](_0x261985[_0x30337d(0x453)],'RcVIz')){if(_0x3683fb[_0x30337d(0x20e)][_0x2c4d5f[_0x30337d(0x4ca)]]['id']===_0x3683fb['correct_choice_id']){if(_0x261985[_0x30337d(0x447)](_0x261985[_0x30337d(0x45d)],_0x261985[_0x30337d(0x285)]))_0x12ac84++,_0x2c4d5f[_0x30337d(0x234)]=_0x261985[_0x30337d(0x353)];else{const _0x5008a5=_0x30da47['fromCharCode'](_0x51f8fe[_0x30337d(0x41b)](0x41,_0x5749d1)),_0x3b5086=_0x152a2b===_0x54a203,_0x1cab0b=_0x40dfc5[_0x30337d(0x4b4)](_0x30337d(0x382));_0x1cab0b[_0x30337d(0x42f)]=_0x30337d(0x266)+(_0x3b5086?_0x51f8fe[_0x30337d(0x46f)]:'')+'\x22\x20data-option-index=\x22'+_0x5b102d+'\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>'+_0x5008a5+_0x30337d(0x24a)+(_0x3579b7[_0x30337d(0x326)]||_0x51f8fe[_0x30337d(0x236)](_0x51f8fe[_0x30337d(0x23c)],_0x51f8fe[_0x30337d(0x41b)](_0x2cb845,0x1)))+_0x30337d(0x370),_0x4a226b[_0x30337d(0x3ef)](_0x1cab0b);}}else _0x261985[_0x30337d(0x3b1)](_0x261985[_0x30337d(0x2b6)],_0x261985[_0x30337d(0x2b6)])?(_0x4d8ef1++,_0x2c4d5f[_0x30337d(0x234)]=_0x261985[_0x30337d(0x3b3)]):_0x5f4c23=_0x10502f;}else _0x49bf2a();}}else _0x51f8fe['Qotij'](_0x341efb);});const _0x383110=JSON[_0x3838c6(0x262)](localStorage[_0x3838c6(0x38b)]('quizPerformanceData'))||[];_0x383110[_0x3838c6(0x46b)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x3838c6(0x357)](),'totalTime':_0x3340e4,'stats':{'correct':_0x12ac84,'incorrect':_0x4d8ef1,'notAttempted':_0x261985[_0x3838c6(0x4c4)](questionsData[_0x3838c6(0x4bf)],_0x12ac84+_0x4d8ef1)}}),localStorage['setItem'](_0x261985[_0x3838c6(0x21a)],JSON[_0x3838c6(0x3b4)](_0x383110)),stats[_0x3838c6(0x25f)]=_0x12ac84,stats[_0x3838c6(0x271)]=_0x4d8ef1,_0x261985['GsnpL'](markQuizAsCompleted),showPerformanceAnalysis(_0x12ac84,_0x4d8ef1,_0x261985[_0x3838c6(0x25a)](questionsData[_0x3838c6(0x4bf)],_0x12ac84+_0x4d8ef1),_0x3340e4);}function showPerformanceAnalysis(_0x2cf210,_0x4c22cf,_0x427a86,_0x437bcd){const _0x49256a=_0x554b79,_0x4e10b5={'TCpbv':_0x49256a(0x451),'NrNUM':function(_0x11dca4,_0x45b1d1){return _0x11dca4>_0x45b1d1;},'AoUdp':function(_0x37b519,_0x5299aa){return _0x37b519+_0x5299aa;},'TKAXn':function(_0x24f0ca,_0x4ca480){return _0x24f0ca*_0x4ca480;},'XBYGx':function(_0x27f628,_0x3b5fbd){return _0x27f628/_0x3b5fbd;},'ZRXDj':function(_0x578205,_0x28d39b){return _0x578205+_0x28d39b;},'HGlyq':function(_0x2b9036,_0x588bd8){return _0x2b9036*_0x588bd8;},'uRUNS':_0x49256a(0x417),'GhOmQ':function(_0x3e0630,_0x19f70c){return _0x3e0630-_0x19f70c;},'MfxnP':function(_0x2c13b1,_0x1dc6fb){return _0x2c13b1*_0x1dc6fb;},'HpDPK':function(_0x4f82db,_0x23aff8){return _0x4f82db/_0x23aff8;},'PUGnW':'accuracyScore','IFzsd':'totalQuestionsResult','yCwrF':_0x49256a(0x200),'jQjJN':_0x49256a(0x4af),'gbLGy':function(_0x1d1c66,_0x18f792){return _0x1d1c66/_0x18f792;},'XWosr':_0x49256a(0x303),'VTrfH':_0x49256a(0x2f8),'bOTKI':_0x49256a(0x2f3)},_0x35a83b=document[_0x49256a(0x26c)](_0x4e10b5[_0x49256a(0x4b5)]),_0x3c04eb=_0x4e10b5['NrNUM'](_0x4e10b5[_0x49256a(0x32d)](_0x2cf210,_0x4c22cf),0x0)?Math[_0x49256a(0x3e7)](_0x4e10b5['TKAXn'](_0x4e10b5[_0x49256a(0x230)](_0x2cf210,_0x4e10b5['ZRXDj'](_0x2cf210,_0x4c22cf)),0x64)):0x0,_0x114b3=_0x4e10b5[_0x49256a(0x488)](_0x4e10b5['TKAXn'](0x2,Math['PI']),0x41),_0x860465=document['getElementById'](_0x4e10b5[_0x49256a(0x3aa)]);_0x860465[_0x49256a(0x28f)]['strokeDasharray']=_0x114b3+'\x20'+_0x114b3,_0x860465[_0x49256a(0x28f)][_0x49256a(0x2e8)]=_0x4e10b5[_0x49256a(0x2aa)](_0x114b3,_0x4e10b5['MfxnP'](_0x4e10b5[_0x49256a(0x2a2)](_0x3c04eb,0x64),_0x114b3)),document['getElementById'](_0x4e10b5['PUGnW'])[_0x49256a(0x37a)]=_0x3c04eb+'%',document[_0x49256a(0x26c)](_0x4e10b5[_0x49256a(0x499)])[_0x49256a(0x37a)]=questionsData[_0x49256a(0x4bf)],document[_0x49256a(0x26c)](_0x4e10b5[_0x49256a(0x20b)])[_0x49256a(0x37a)]=_0x2cf210,document[_0x49256a(0x26c)](_0x49256a(0x419))[_0x49256a(0x37a)]=_0x4c22cf,document[_0x49256a(0x26c)](_0x4e10b5[_0x49256a(0x384)])[_0x49256a(0x37a)]=_0x427a86;const _0xbd721a=Math['floor'](_0x4e10b5[_0x49256a(0x230)](_0x437bcd,0xea60)),_0x18d695=Math[_0x49256a(0x270)](_0x4e10b5['gbLGy'](_0x437bcd%0xea60,0x3e8));document[_0x49256a(0x26c)](_0x4e10b5[_0x49256a(0x3a3)])['textContent']=_0xbd721a+':'+_0x18d695[_0x49256a(0x21f)]()[_0x49256a(0x31f)](0x2,'0');const _0x50e42c=_0x437bcd/questionsData[_0x49256a(0x4bf)],_0x399708=Math[_0x49256a(0x270)](_0x50e42c/0xea60),_0x284375=Math[_0x49256a(0x270)](_0x50e42c%0xea60/0x3e8);document[_0x49256a(0x26c)](_0x4e10b5[_0x49256a(0x35c)])['textContent']=_0x399708+':'+_0x284375[_0x49256a(0x21f)]()[_0x49256a(0x31f)](0x2,'0'),_0x35a83b[_0x49256a(0x2d1)]['remove'](_0x4e10b5[_0x49256a(0x478)]);}function closePerformanceModal(){const _0xf8fc6f=_0x554b79;document[_0xf8fc6f(0x26c)]('performanceModal')[_0xf8fc6f(0x2d1)][_0xf8fc6f(0x205)](_0xf8fc6f(0x2f3));}function reviewQuestions(){const _0x379d92=_0x554b79,_0x45f760={'iLApH':function(_0x9f7ad3,_0x490294){return _0x9f7ad3(_0x490294);},'LrObb':_0x379d92(0x30c),'pozef':_0x379d92(0x397),'OGORB':_0x379d92(0x2c0),'kTNQE':_0x379d92(0x32a),'upESh':_0x379d92(0x213),'wfOrJ':function(_0x3e0474,_0x3e61dd){return _0x3e0474!==_0x3e61dd;},'ECGfn':function(_0x40d414,_0x577616){return _0x40d414!==_0x577616;},'QyoLb':'ATIKO','trcfJ':'hWQrB','hjzzP':function(_0x4dd867,_0x1fcd26){return _0x4dd867===_0x1fcd26;},'DwxxG':_0x379d92(0x2bf),'uMQXh':_0x379d92(0x43a),'SHRZk':_0x379d92(0x45b),'UVCGJ':'div','CRBQe':function(_0x1c54d8,_0x52ca8e){return _0x1c54d8+_0x52ca8e;},'bsUgP':_0x379d92(0x328),'vNPYK':function(_0x6abff,_0x2d22ea){return _0x6abff===_0x2d22ea;},'IqnFT':_0x379d92(0x2a5),'UbluA':_0x379d92(0x33f),'WlHGK':_0x379d92(0x468),'MQqta':_0x379d92(0x311),'JxBNi':_0x379d92(0x3d1),'KFUxO':_0x379d92(0x2f3),'CTwvN':_0x379d92(0x3f1)};document['getElementById'](_0x45f760['JxBNi'])[_0x379d92(0x2d1)]['remove'](_0x45f760[_0x379d92(0x38e)]);const _0x4273e2=document[_0x379d92(0x26c)](_0x45f760[_0x379d92(0x332)]);_0x4273e2['innerHTML']='',questionsData[_0x379d92(0x442)]((_0x488581,_0x4f1a30)=>{const _0xcb6a12=_0x379d92,_0x48056d={'GNALs':_0x45f760[_0xcb6a12(0x2c2)],'EbnFt':_0x45f760['kTNQE']},_0x4c1a97=questionStates[_0x4f1a30],_0x364f05=_0x488581[_0xcb6a12(0x281)];let _0x3a6f5f=_0x45f760[_0xcb6a12(0x297)],_0xddccc8=_0xcb6a12(0x48b);if(_0x45f760[_0xcb6a12(0x3e9)](_0x4c1a97[_0xcb6a12(0x4ca)],null)){if(_0x45f760['ECGfn'](_0x45f760[_0xcb6a12(0x24c)],_0x45f760['trcfJ'])){const _0x394300=_0x488581[_0xcb6a12(0x20e)][_0x4c1a97[_0xcb6a12(0x4ca)]];_0x45f760[_0xcb6a12(0x304)](_0x394300['id'],_0x364f05)?(_0x3a6f5f=_0x45f760[_0xcb6a12(0x47d)],_0xddccc8=_0x45f760[_0xcb6a12(0x3d4)]):(_0x3a6f5f='incorrect',_0xddccc8=_0x45f760[_0xcb6a12(0x29f)]);}else _0x45f760[_0xcb6a12(0x345)](_0x4c460e,_0xcb6a12(0x2c9))&&(_0x4923b5[_0xcb6a12(0x237)][_0xcb6a12(0x4ae)][_0xcb6a12(0x25d)](_0x45f760[_0xcb6a12(0x4a8)])&&_0x301ddd[_0xcb6a12(0x302)](_0x45f760[_0xcb6a12(0x294)]),_0x513776(),_0x3122d7[_0xcb6a12(0x3f7)]());}const _0x41216b=document[_0xcb6a12(0x4b4)](_0x45f760[_0xcb6a12(0x279)]);_0x41216b[_0xcb6a12(0x3ff)]=_0xcb6a12(0x3f4)+_0x3a6f5f;let _0x4f9f22=(_0x488581[_0xcb6a12(0x20e)]||[])[_0xcb6a12(0x243)]((_0x4f0f2b,_0x579b80)=>{const _0x4c9772=_0xcb6a12;if(_0x48056d[_0x4c9772(0x430)]===_0x48056d['GNALs']){const _0x54cd2d=_0x4c1a97[_0x4c9772(0x4ca)]===_0x579b80,_0x6afc72=_0x4f0f2b['id']===_0x364f05;let _0x33df9d=_0x48056d[_0x4c9772(0x292)];if(_0x6afc72)_0x33df9d=_0x4c9772(0x308);else{if(_0x54cd2d)_0x33df9d=_0x4c9772(0x36a);}return _0x4c9772(0x4a4)+_0x33df9d+_0x4c9772(0x21b)+String[_0x4c9772(0x209)](0x41+_0x579b80)+'</span><span>'+_0x4f0f2b[_0x4c9772(0x326)]+_0x4c9772(0x43d);}else _0x24db6f[_0x4c9772(0x302)](_0x4c9772(0x397));})[_0xcb6a12(0x316)]('');const _0x5b89db=_0x488581['explanation_video']?_0xcb6a12(0x346)+_0x4f1a30+'\x22\x20data-src=\x22'+_0x488581['explanation_video']+_0xcb6a12(0x456):'';let _0x2450c4='';if(_0x488581[_0xcb6a12(0x349)])_0x2450c4+=_0xcb6a12(0x38c)+_0x488581[_0xcb6a12(0x349)]+_0xcb6a12(0x3bd);if(_0x488581[_0xcb6a12(0x457)])_0x2450c4+=_0xcb6a12(0x244)+_0x488581[_0xcb6a12(0x457)]+_0xcb6a12(0x3bd);let _0x392faf=(_0x488581[_0xcb6a12(0x2f9)]||[])[_0xcb6a12(0x243)](_0x296fc2=>_0x296fc2?_0xcb6a12(0x3c0)+_0x296fc2+_0xcb6a12(0x33b):'')[_0xcb6a12(0x316)]('');_0x41216b[_0xcb6a12(0x42f)]='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20'+_0x45f760[_0xcb6a12(0x21e)](_0x4f1a30,0x1)+_0xcb6a12(0x44d)+(_0x45f760[_0xcb6a12(0x304)](_0x3a6f5f,_0xcb6a12(0x2bf))?_0x45f760[_0xcb6a12(0x325)]:_0x45f760[_0xcb6a12(0x365)](_0x3a6f5f,_0x45f760['IqnFT'])?_0x45f760['UbluA']:_0x45f760[_0xcb6a12(0x466)])+_0xcb6a12(0x248)+_0xddccc8+_0xcb6a12(0x3d8)+_0x488581[_0xcb6a12(0x326)]+_0xcb6a12(0x4b1)+_0x4f9f22+_0xcb6a12(0x2e3)+(_0x488581[_0xcb6a12(0x228)]||_0x45f760[_0xcb6a12(0x3f6)])+_0xcb6a12(0x4b8)+_0x5b89db+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20'+_0x2450c4+_0xcb6a12(0x41d)+_0x392faf+_0xcb6a12(0x28d),_0x4273e2[_0xcb6a12(0x3ef)](_0x41216b);}),initializeReviewVideos();}function initializeReviewVideos(){const _0x367224=_0x554b79,_0x57cfac={'lOSao':function(_0x26f115,_0x397cea){return _0x26f115(_0x397cea);},'REeOt':_0x367224(0x2b2),'AwciG':function(_0x447784,_0x1aa6df){return _0x447784===_0x1aa6df;},'gKAPe':'pfyTi','pLBjr':_0x367224(0x231),'BbteV':_0x367224(0x327),'aSlmr':function(_0x3e2e50,_0x5c59d6,_0x3a9a55){return _0x3e2e50(_0x5c59d6,_0x3a9a55);},'jzpMR':_0x367224(0x3f8)};document[_0x367224(0x443)](_0x57cfac[_0x367224(0x39b)])[_0x367224(0x442)](_0x234f8b=>{const _0x3f235e=_0x367224,_0x2300b4={'PWskM':function(_0x2eb94a,_0x52366e){const _0x2a09be=_0x3765;return _0x57cfac[_0x2a09be(0x431)](_0x2eb94a,_0x52366e);},'BwgvU':_0x57cfac[_0x3f235e(0x251)]};if(_0x57cfac[_0x3f235e(0x428)](_0x57cfac[_0x3f235e(0x3a2)],_0x57cfac[_0x3f235e(0x42a)])){const _0x4e0a35=_0x2300b4[_0x3f235e(0x423)](_0x103e7a,_0x309f43[_0x3f235e(0x2d7)](_0x2300b4[_0x3f235e(0x475)]));_0x2300b4[_0x3f235e(0x423)](_0x5e0f06,_0x4e0a35);}else{const _0x3e8873=_0x234f8b['dataset']['src'];if(_0x3e8873&&_0x3e8873[_0x3f235e(0x355)](_0x57cfac[_0x3f235e(0x356)]))_0x57cfac[_0x3f235e(0x454)](setupVideo,_0x234f8b,_0x3e8873);else _0x3e8873&&(_0x234f8b['src']=_0x3e8873);}});}function retakeQuiz(){const _0x28ad2a=_0x554b79,_0x54335c={'nQhLM':_0x28ad2a(0x2a5),'yjuJa':_0x28ad2a(0x45b),'wjGwj':function(_0x48cba7,_0x1d32b7){return _0x48cba7(_0x1d32b7);},'GWDmd':'Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','VIHcE':'custom_quiz.html','jcBhC':function(_0x1e3912,_0x11e763){return _0x1e3912!==_0x11e763;},'Ugjgf':_0x28ad2a(0x354)};_0x54335c[_0x28ad2a(0x4c0)](confirm,_0x54335c[_0x28ad2a(0x410)])&&(window[_0x28ad2a(0x237)][_0x28ad2a(0x4ae)][_0x28ad2a(0x25d)](_0x54335c[_0x28ad2a(0x49a)])&&(_0x54335c[_0x28ad2a(0x256)](_0x54335c[_0x28ad2a(0x299)],_0x54335c[_0x28ad2a(0x299)])?(_0x555c8f=_0x54335c[_0x28ad2a(0x3a9)],_0x25a96b=_0x54335c['yjuJa']):localStorage[_0x28ad2a(0x302)](_0x28ad2a(0x397))),clearProgress(),location[_0x28ad2a(0x3f7)]());}function loadBookmarkedQuestions(){const _0x4eaea7=_0x554b79,_0x532310={'SrMmB':function(_0x13a30a,_0x1e7526){return _0x13a30a<_0x1e7526;},'JdEty':'bookmarkedQuestions'},_0x513a75=JSON['parse'](localStorage[_0x4eaea7(0x38b)](_0x532310[_0x4eaea7(0x46d)]))||[];_0x513a75[_0x4eaea7(0x442)](_0x4f3764=>{const _0xca2d94=_0x4eaea7;_0x4f3764['quizFile'][_0xca2d94(0x355)](quizName['toLowerCase']()['replace'](/ /g,'-'))&&(_0x532310[_0xca2d94(0x2fa)](_0x4f3764[_0xca2d94(0x342)],questionsData[_0xca2d94(0x4bf)])&&(questionStates[_0x4f3764[_0xca2d94(0x342)]]['bookmarked']=!![]));});}function toggleBookmark(){const _0x53fd01=_0x554b79,_0x307f76={'IiUIn':_0x53fd01(0x202),'ldBuf':function(_0x57eb25){return _0x57eb25();}},_0x2e1f37=!questionStates[currentQuestionIndex][_0x53fd01(0x369)];questionStates[currentQuestionIndex][_0x53fd01(0x369)]=_0x2e1f37;let _0x415b84=JSON[_0x53fd01(0x262)](localStorage[_0x53fd01(0x38b)](_0x307f76[_0x53fd01(0x2d5)]))||[];if(_0x2e1f37){const _0x1eab5c={'quizName':quizName,'quizFile':window['location']['pathname'][_0x53fd01(0x374)]('/')[_0x53fd01(0x2d4)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0x53fd01(0x357)]()};_0x415b84['push'](_0x1eab5c);}else _0x415b84=_0x415b84[_0x53fd01(0x347)](_0x56067e=>!(_0x56067e[_0x53fd01(0x42e)][_0x53fd01(0x355)](quizName[_0x53fd01(0x41c)]()[_0x53fd01(0x2fb)](/ /g,'-'))&&_0x56067e[_0x53fd01(0x342)]===currentQuestionIndex));localStorage[_0x53fd01(0x49c)](_0x307f76[_0x53fd01(0x2d5)],JSON[_0x53fd01(0x3b4)](_0x415b84)),_0x307f76[_0x53fd01(0x229)](updateBookmarkButton),_0x307f76[_0x53fd01(0x229)](updateQuestionNav);}function updateBookmarkButton(){const _0x4c3d16=_0x554b79,_0x1cf716={'jzMSL':'bookmarkText','MlipZ':_0x4c3d16(0x446),'THCCF':_0x4c3d16(0x3d5),'Xtvhn':'Bookmarked'},_0x7d374c=document[_0x4c3d16(0x26c)](_0x4c3d16(0x23e)),_0x461651=document[_0x4c3d16(0x26c)](_0x1cf716[_0x4c3d16(0x27c)]),_0x3a6977=questionStates[currentQuestionIndex]['bookmarked'];_0x7d374c['className']=_0x3a6977?_0x1cf716[_0x4c3d16(0x3d3)]:_0x1cf716[_0x4c3d16(0x363)],_0x461651[_0x4c3d16(0x37a)]=_0x3a6977?_0x1cf716[_0x4c3d16(0x27f)]:_0x4c3d16(0x39e);}function toggleMarkForReview(){const _0x2fc79d=_0x554b79,_0x3e392d={'ZOvii':function(_0x58d20d){return _0x58d20d();}};questionStates[currentQuestionIndex][_0x2fc79d(0x38a)]=!questionStates[currentQuestionIndex]['markedForReview'],_0x3e392d[_0x2fc79d(0x41f)](updateMarkReviewButton),updateQuestionNav();}function _0x1ec7(){const _0x58d5a2=['WnOUz','zjPxw','gKAPe','XWosr','constructor','<p><span\x20style=\x22font-size:12.0pt;\x22>Multiple\x20myeloma</span></p>','quizPerformanceData','<p><span\x20style=\x22font-size:12.0pt;\x22>TIBC\x20&times;\x20100\x20&divide;\x20serum\x20iron</span></p>','DT1192323','nQhLM','uRUNS','TBkax','<p><strong>Explanation:</strong></p>\x0a<p>The\x20second\x20most\x20common\x20cause\x20of\x20death\x20by\x20cancer\x20in\x20females\x20is<strong>\x20breast\x20cancer</strong>.</p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024032760fc16f3-384b-45c9-b450-2667d79ee71a.jpg\x22>','solutionImages','sEPGD','<p><span\x20style=\x22font-size:12.0pt;\x22>Aplastic\x20anemia</span></p>','HhNRc','Gwtzz','1542880BgqxLQ','Yesfj','stringify','SgWdi','<p><span\x20style=\x22font-size:12.0pt;\x22>Inhibitor\x20of\x20PD-1</span></p>','BvsfB','explanation_video','aNEVk','<p><span\x20style=\x22font-size:12.0pt;\x22>G6PD\x20deficiency</span></p>','BkaiF','<p><span\x20style=\x22font-size:12.0pt;\x22>Serum\x20ferritin\x20&times;\x20100\x20&divide;\x20Serum\x20Iron</span></p>','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','BEScp','explanationVideoPlayer','<div\x20class=\x22mt-4\x22><img\x20src=\x22','trace','kFSIY','<p><strong>Explanation:</strong></p>\x0a<p>All\x20the\x20given\x20options\x20are\x20causes\x20of\x20pancytopenia\x20with\x20hypocellular\x20bone\x20marrow.</p>\x0a<p>The\x20differential\x20diagnosis\x20for\x20pancytopenia\x20is\x20given\x20in\x20the\x20table\x20below.</p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025091211ed54a5-7e31-485c-bcf8-d335fbd4f906.png\x22>','\x22\x20data-option-index=\x22','MNEvx','Taqjn','SMcTL','<p><span\x20style=\x22font-size:12.0pt;\x22>Transferrin\x20saturation\x20is\x20calculated\x20by?</span></p>','vsbqK','NlXOp','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','cRShd','hierarchy','KOgBN','No\x20questions\x20available\x20for\x20this\x20quiz.','STEDl','questionReviewSection','wpSex','MlipZ','uMQXh','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','KuubA','currentMode','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','userHistory','qRuug','FstoM','<p><span\x20style=\x22font-size:12.0pt;\x22>Fanconi\x20anemia</span></p>','block','QpRAR','LmMhG','oCXbO','dlRwK','ZoUIv','questions','Marked','<p><span\x20style=\x22font-size:12.0pt;\x22>Sickle\x20cell\x20anemia</span></p>','GlRBV','round','questionStates','wfOrJ','nav-btn-bookmarked','<p><span\x20style=\x22font-size:12.0pt;\x22>CD\x2020\x20monoclonal\x20antibody</span></p>','iCIuY','LGDjU','quizHierarchy','appendChild','FOkYh','reviewQuestionsContainer','MsbcI','SSSkH','review-question\x20','canPlayType','MQqta','reload','video[data-src]','rXUBp','KjqUN','DT1192340','UskAl','ZQfgK','UYKoo','className','totalTime','uKaEF','IfZAc','prevBtn','<p><strong>Explanation:</strong></p>\x0a<p>Rituximab\x20is\x20an<strong>\x20anti-CD20\x20antibody</strong>.</p>\x0a<ul>\x0a<li>Rituximab\x20is\x20a\x20monoclonal\x20antibody\x20targeting\x20the\x20CD20\x20antigen\x20on\x20<strong>B-cells</strong>.\x20It\x20acts\x20primarily\x20through\x20complement-dependent\x20cytotoxicity\x20and\x20antibody-dependent\x20cellular\x20cytotoxicity,\x20leading\x20to\x20B-cell\x20depletion.\x20(Option\x20A\x20ruled\x20out)</li>\x0a<li>This\x20effect\x20begins\x20within\x20three\x20weeks\x20of\x20therapy\x20and\x20can\x20last\x206\x20to\x209\x20months.\x20B-cell\x20counts\x20usually\x20return\x20to\x20normal\x20by\x2012\x20months.</li>\x0a<li>The\x20drug\x20is\x20administered<strong>\x20intravenously</strong>\x20either\x20alone\x20or\x20in\x20combination\x20with\x20chemotherapy.</li>\x0a<li>To\x20minimize\x20infusion\x20reactions,\x20premedication\x20with\x20antihistamines,\x20acetaminophen,\x20and\x20steroids\x20is\x20recommended.</li>\x0a<li>Rituximab\x20is\x20approved\x20for\x20relapsed\x20indolent\x20lymphomas\x20and\x20is\x20effective\x20in\x20combination\x20with\x20chemotherapy\x20for\x20<strong>diffuse\x20large\x20B-cell\x20lymphoma</strong>\x20and\x20other\x20B-cell\x20non-Hodgkin\x20lymphomas\x20like\x20CLL,\x20<strong>mantle\x20cell\x20lymphoma</strong>,\x20and\x20Waldenstr&ouml;m\x20macroglobulinemia.</li>\x0a<li>Its\x20indications\x20have\x20expanded\x20to\x20several\x20autoimmune\x20disorders\x20such\x20as\x20<strong>rheumatoid\x20arthritis</strong>,\x20autoimmune\x20hemolytic\x20anemia,\x20and\x20cryoglobulinemia-associated\x20renal\x20disease.</li>\x0a<li>Resistance\x20may\x20occur\x20due\x20to\x20loss\x20or\x20<strong>mutation\x20of\x20CD20,</strong>\x20impaired\x20complement\x20function,\x20or\x20Fc\x20receptor\x20polymorphisms.\x20Infusion-related\x20reactions\x20are\x20usually\x20mild\x20(fever,\x20urticaria,\x20hypotension),\x20but\x20rarely\x20can\x20include\x20severe\x20mucocutaneous\x20reactions\x20like\x20<strong>Stevens-Johnson\x20syndrome</strong>.</li>\x0a<li>Rituximab\x20may<strong>\x20reactivate\x20hepatitis\x20B\x20or\x20JC\x20virus</strong>\x20and\x20is\x20linked\x20to\x20delayed\x20autoimmune\x20cytopenias\x20(e.g.,\x20ITP,\x20autoimmune\x20hemolytic\x20anemia,\x20pure\x20red\x20cell\x20aplasia)\x20that\x20may\x20emerge\x201-5\x20months\x20post-treatment.</li>\x0a</ul>\x0a<p><strong>Explanations\x20of\x20other\x20options:</strong></p>\x0a<p><strong>Inhibitor\x20of\x20PD-1\x20(Option\x20C):\x20</strong>\x20An\x20example\x20of\x20PD-1\x20inhibitor\x20(immune\x20checkpoint\x20inhibitor)\x20is\x20nivolumab.</p>\x0a<p><strong>Anti\x20CD52\x20monoclonal\x20antibody\x20(Option\x20D):</strong>\x20An\x20example\x20is\x20alemtuzumab\x20which\x20is\x20used\x20in\x20B-cell\x20CLL</p>','xDyTG','DT1192318','DT1192312','timed_exam','IJHWe','currentQuestionIndex','DT1192258','<p><span\x20style=\x22font-size:12.0pt;\x22>Kostmann\x20syndrome</span></p>','dpBSO','Factual','notAttempted','GWDmd','HEGBY','yXOXU','hxUUx','<p><span\x20style=\x22font-size:12.0pt;\x22>12&deg;\x20C</span></p>','DHfVm','aSZLP','scoreCircle','incorrectCount','incorrectResult','<p><strong>Explanation:</strong></p>\x0a<p>The\x20most\x20efficient\x20antigen\x20presenting\x20cell\x20is\x20the\x20<strong>dendritic\x20cell</strong>.</p>\x0a<ul>\x0a<li>Dendritic\x20cells,\x20also\x20known\x20as\x20interdigitating\x20dendritic\x20cells,\x20serve\x20as\x20the\x20principal\x20antigen-presenting\x20cells\x20responsible\x20for\x20initiating\x20<strong>T-cell\x20responses</strong>\x20to\x20protein\x20antigens.</li>\x0a<li>They\x20are\x20primarily\x20located\x20within\x20epithelial\x20tissues\x20and\x20the\x20interstitium\x20and\x20possess\x20a\x20variety\x20of\x20receptors\x20such\x20as<strong>\x20toll-like\x20receptors\x20(TLRs)</strong>\x20and<strong>\x20lectins</strong>\x20that\x20help\x20them\x20detect\x20and\x20respond\x20to\x20microbes\x20and\x20other\x20antigens.</li>\x0a<li>These\x20cells\x20also\x20exhibit\x20elevated\x20levels\x20of\x20<strong>major\x20histocompatibility\x20complex\x20(MHC)\x20</strong>molecules,\x20which\x20are\x20critical\x20for\x20presenting\x20antigens\x20and\x20activating\x20T\x20cells.\x20(Option\x20A\x20ruled\x20out)</li>\x0a<li>Upon\x20encountering\x20microbes,\x20dendritic\x20cells\x20migrate\x20to\x20T-cell\x20areas\x20of\x20lymphoid\x20tissues,\x20where\x20they\x20display\x20antigens\x20to\x20T\x20cells\x20using\x20MHC\x20molecules.</li>\x0a<li>There\x20are\x20other\x20cells\x20with\x20a\x20dendritic\x20shape\x20found\x20in\x20the\x20germinal\x20centers\x20of\x20lymphoid\x20follicles\x20in\x20organs\x20like\x20the\x20spleen\x20and\x20lymph\x20nodes\x20which\x20are\x20known\x20as\x20follicular\x20dendritic\x20cells.</li>\x0a<li>These\x20cells\x20have\x20receptors\x20for\x20the\x20Fc\x20region\x20of\x20IgG\x20and\x20for\x20the\x20complement\x20component\x20C3b.</li>\x0a<li>In\x20the\x20epidermis,\x20the\x20immature\x20form\x20of\x20dendritic\x20cells\x20is\x20referred\x20to\x20as\x20<strong>Langerhans\x20cells</strong>.</li>\x0a</ul>','trtBk','toLowerCase','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','<p><strong>Explanation:</strong></p>\x0a<p><strong>Bortezomib</strong>\x20is\x20a<strong>\x20proteasome\x20inhibitor</strong>,\x20used\x20in\x20<strong>multiple\x20myeloma\x20and\x20mantle\x20cell\x20lymphoma.</strong></p>\x0a<ul>\x0a<li>Bortezomib\x20is\x20a\x20<strong>first-generation\x20proteasome\x20inhibitor</strong>\x20that\x20blocks\x20the\x20&beta;5\x20subunit\x20of\x20the\x2020S\x20core\x20of\x20the\x2026S\x20proteasome,\x20thereby\x20<strong>inhibiting\x20chymotrypsin-like\x20activity</strong>\x20and\x20<strong>inducing\x20apoptosis</strong>\x20through\x20disruption\x20of\x20signaling\x20pathways.</li>\x0a<li>One\x20of\x20its\x20main\x20effects\x20is\x20blocking\x20NF-&kappa;B\x20activation\x20by\x20preventing\x20degradation\x20of\x20I&kappa;B\x20(inhibitor\x20of\x20NF-&kappa;B),\x20thereby\x20inhibiting\x20survival\x20signals\x20in\x20tumor\x20cells.</li>\x0a<li>It\x20also\x20affects\x20cell\x20cycle\x20regulators\x20and\x20promotes\x20apoptosis\x20by\x20disturbing\x20the\x20protein\x20degradation\x20process\x20and\x20<strong>inducing\x20unfolded\x20protein\x20response</strong>.</li>\x0a<li>The\x20drug\x20is\x20administered\x20intravenously\x20on\x20specific\x20days\x20of\x20a\x2021-day\x20cycle,\x20with\x20a\x20necessary\x2072-hour\x20gap\x20between\x20doses.\x20It\x20has\x20a\x20plasma\x20half-life\x20of\x205.5\x20hours\x20and\x20a\x20terminal\x20half-life\x20of\x20approximately\x2024\x20hours.\x20It\x20is\x20metabolized\x20primarily\x20by\x20CYP3A4,\x20and\x20no\x20dose\x20modification\x20is\x20needed\x20for\x20renal\x20impairment.</li>\x0a<li>Therapeutically,\x20Bortezomib\x20is\x20used\x20in\x20initial\x20and\x20relapsed\x20settings\x20for\x20<strong>multiple\x20myeloma</strong>\x20(MM)\x20and<strong>\x20mantle\x20cell\x20lymphoma\x20</strong>(MCL).\x20(Options\x20C\x20and\x20D\x20ruled\x20out)</li>\x0a<li>It\x20is\x20especially\x20effective\x20when\x20combined\x20with\x20agents\x20like\x20thalidomide\x20or\x20dexamethasone,\x20achieving\x20high\x20response\x20rates\x20in\x20relapsed/refractory\x20myeloma.</li>\x0a<li>Adverse\x20effects\x20include\x20<strong>thrombocytopenia</strong>,\x20fatigue,\x20<strong>peripheral\x20neuropathy\x20</strong>(especially\x20in\x20those\x20with\x20prior\x20neurotoxic\x20exposure),\x20gastrointestinal\x20symptoms,\x20and\x20hypotension.\x20(Option\x20A\x20ruled\x20out)</li>\x0a<li>Peripheral\x20neuropathy\x20may\x20be\x20chronic\x20and\x20more\x20frequent\x20in\x20diabetic\x20or\x20thalidomide-treated\x20patients.\x20Discontinuation\x20or\x20dose\x20reduction\x20can\x20help\x20alleviate\x20symptoms.</li>\x0a</ul>','ZOvii','solutionAudio','\x20-\x20Brain\x20And\x20Scalpel','HynyC','PWskM','<p><span\x20style=\x22font-size:12.0pt;\x22>Copper\x20deficiency</span></p>','log','<p><strong>Explanation:</strong></p>\x0a<p>When\x20the\x20bone\x20marrow\x20is\x20replaced\x20by\x20fibrous\x20tissue\x20secondary\x20to\x20<strong>granulomatous\x20process</strong>\x20or\x20<strong>tumour</strong>\x20it\x20is\x20called\x20<strong>myelophthisis</strong>.</p>\x0a<ul>\x0a<li>When\x20the\x20bone\x20marrow\x20cavity\x20is\x20replaced\x20by\x20fibrous\x20tissue\x20made\x20up\x20of<strong>\x20reticulin\x20fibers</strong>\x20and\x20collagen,\x20it\x20can\x20be\x20classified\x20as\x20either\x20myelofibrosis\x20or\x20myelophthisis\x20depending\x20on\x20the\x20cause.</li>\x0a<li>If\x20the\x20fibrosis\x20results\x20from\x20a\x20primary<strong>\x20hematologic\x20disorder,</strong>\x20it\x20is\x20termed\x20myelofibrosis.</li>\x0a<li>On\x20the\x20other\x20hand,\x20when\x20fibrosis\x20is\x20a\x20consequence\x20of\x20external\x20factors\x20like\x20tumors\x20or\x20granulomatous\x20disease\x20infiltrating\x20the\x20marrow,\x20it\x20is\x20referred\x20to\x20as\x20myelophthisis.</li>\x0a<li>Myelophthisis\x20or\x20fibrosis\x20may\x20be\x20suspected\x20when\x20bone\x20marrow\x20aspiration\x20yields\x20little\x20or\x20no\x20material\x20which\x20is\x20commonly\x20referred\x20to\x20as\x20a\x20\x22dry\x20tap.\x22</li>\x0a</ul>\x0a<p>The\x20image\x20given\x20below\x20shows\x20bone\x20marrow\x20replaced\x20by\x20fibrous\x20tissue.</p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240327b72a21bd-8e1f-47ce-ba97-25ba39a26e4f.jpg\x22>','<p><span\x20style=\x22font-size:12.0pt;\x22>All\x20are\x20criteria\x20for\x20accelerated\x20blast\x20phase\x20except?</span></p>','AwciG','VRivi','pLBjr','info','<p><span\x20style=\x22font-size:12.0pt;\x22>Dasatinib</span></p>','DT1192264','quizFile','innerHTML','GNALs','lOSao','lNJyq','YWlrA','HPaeT','dUwCP','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20blood\x20group\x20is\x20more\x20prone\x20to\x20Helicobacter\x20pylori\x20infections?</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>O</span></p>','ijQzS','KeIPb','Correct','xTYef','whXNs','</span></div>','<p><span\x20style=\x22font-size:12.0pt;\x22>The\x20second\x20most\x20common\x20cause\x20of\x20death\x20by\x20cancer\x20in\x20females\x20is?</span></p>','<p><strong>Explanation:</strong></p>\x0a<p>Among\x20the\x20given\x20options,\x20<strong>functional\x20extranodal\x20involvement</strong>\x20is\x20a\x20criteria\x20for\x20initiation\x20of\x20therapy\x20in\x20CLL.</p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403278cbaec36-3725-4de5-b34f-e22b6b0b1d03.jpg\x22>','question_images','YCcjI','forEach','querySelectorAll','MjjeO','Hematology\x20Part\x201','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','LbQCD','key','<p><span\x20style=\x22font-size:12.0pt;\x22>Tyrosine\x20kinase\x20inhibitor</span></p>','DT1192257','2970205zfOorq','<p><span\x20style=\x22font-size:12.0pt;\x22>Good\x20prognosis</span></p>','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','IOqWu','title','DT1192332','performanceModal','gJBkX','FUiPm','aSlmr','<p><span\x20style=\x22font-size:12.0pt;\x22>Peripheral\x20blood\x20smear\x20of\x20a\x20patient\x20is\x20given\x20below.\x20The\x20given\x20finding\x20is\x20seen\x20in\x20which\x20of\x20the\x20following\x20conditions?<br><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403271547a28f-b982-4a35-9c1e-3eb482dedd96.jpg\x22></span></p>','\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>','explanation_audio_hin','<p><span\x20style=\x22font-size:12.0pt;\x22>Identify\x20the\x20causes\x20of\x20myelofibrosis</span></p>','DbgOM','77905qoXNJM','Incorrect','DT1192220','foyIp','qNyae','DT1192308','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','pAhyk','SjTnN','FbUTA','3|4|0|5|1|2','currentQuestion','WlHGK','quizSidebar','gray','studyModeLegend','toggle','push','<p><span\x20style=\x22font-size:12.0pt;\x22>7</span></p>','JdEty','modeModal','pChRq','65046pGSxrU','prototype','fSJzp','progressBar','pTDGA','BwgvU','flex','{}.constructor(\x22return\x20this\x22)(\x20)','bOTKI','name','tykCA','qTFRy','<p><span\x20style=\x22font-size:12.0pt;\x22>Treatment\x20related\x20thrombocytopenia\x20<100\x20*\x2010<sup>9</sup>/L</span></p>','DwxxG','<p><span\x20style=\x22font-size:12.0pt;\x22>Inj\x20Cytarabine\x20(100-200mg/m2)\x20+\x20Inj\x20Daunorubicin\x20(45\x20mg/m2)\x20[7+3\x20regimen]</span></p>','cgJtb','<p><span\x20style=\x22font-size:12.0pt;\x22>Dyskeratosis\x20congenita</span></p>','fill','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','DT1192225','GiJqy','osuHk','<p><span\x20style=\x22font-size:12.0pt;\x22>Evidence\x20of\x20progressive\x20marrow\x20failure\x20due\x20to\x20autoimmune\x20destruction</span></p>','FIXWd','HGlyq','qdGTx','nav-btn-incorrect','Not\x20Attempted','rWSFO','hghqb','fTpXI','<p><span\x20style=\x22font-size:12.0pt;\x22>Hyperuricemia</span></p>','hYKjX','<p><span\x20style=\x22font-size:12.0pt;\x22>Ponatinib</span></p>','yboMp','xxNyD','<p><span\x20style=\x22font-size:12.0pt;\x22>Deletion\x2020</span></p>','bookmarkText','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','resume','GpJea','IFzsd','VIHcE','<p><span\x20style=\x22font-size:12.0pt;\x22>Lymphocytosis\x20only</span></p>','setItem','mEdCO','bottom','navBtn_','CZcyp','markReviewBtn','6549867lzNJhl','DT1192261','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','target','jTReD','tTcBb','LrObb','<p><span\x20style=\x22font-size:12.0pt;\x22>8&deg;\x20C</span></p>','open','xduSs','Hmelx','ckcfZ','pathname','notAttemptedResult','HGuGw','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','yesDA','JXQFW','createElement','TCpbv','VpJjX','index.html','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','<p><strong>Explanation:</strong></p>\x0a<p>For\x20maximal\x20oral\x20absorption\x20<strong>oral\x20iron\x20preparations</strong>\x20should\x20be\x20taken\x20on\x20an\x20<strong>empty\x20stomach</strong>.</p>\x0a<ul>\x0a<li>In\x20patients\x20with\x20confirmed\x20iron\x20deficiency\x20anemia\x20and\x20a\x20functioning\x20gastrointestinal\x20tract,\x20oral\x20iron\x20therapy\x20is\x20typically\x20effective.</li>\x0a<li>Emphasis\x20is\x20placed\x20on\x20increasing\x20consumption\x20of\x20iron-rich\x20foods\x20like\x20oysters,\x20legumes,\x20meats\x20(especially\x20liver\x20and\x20lean\x20cuts),\x20whole\x20grains,\x20and\x20fortified\x20cereals.</li>\x0a<li>Oral\x20supplements\x20are\x20available\x20in\x20various\x20formulations,\x20from\x20simple\x20salts\x20to\x20complex\x20compounds.</li>\x0a<li>Usually,\x20up\x20to\x20200\x20mg\x20of\x20elemental\x20iron\x20per\x20day\x20is\x20prescribed,\x20divided\x20into\x203-4\x20doses.</li>\x0a<li>Iron\x20is\x20best\x20absorbed\x20on\x20an\x20<strong>empty\x20stomach</strong>,\x20although\x20gastric\x20conditions\x20or\x20prior\x20surgeries\x20may\x20reduce\x20absorption.</li>\x0a<li>Approximately\x2050\x20mg/day\x20is\x20absorbed\x20from\x20this\x20dose,\x20enough\x20to\x20triple\x20red\x20cell\x20production\x20under\x20erythropoietin\x20stimulation.</li>\x0a<li>Therapy\x20should\x20continue\x20for\x20<strong>6-12\x20months</strong>\x20to\x20restore\x20iron\x20stores\x20(at\x20least\x200.5-1\x20g),\x20beyond\x20just\x20correcting\x20anemia.</li>\x0a<li>However,\x20<strong>gastrointestinal\x20side\x20effects</strong>\x20(like\x20nausea,\x20pain,\x20vomiting,\x20and\x20constipation)\x20occur\x20in\x20some\x20patients\x20and\x20can\x20reduce\x20compliance.\x20Modified-release\x20or\x20lower-dose\x20options\x20may\x20help\x20alleviate\x20this.</li>\x0a<li>Reticulocyte\x20counts\x20usually\x20rise\x20within<strong>\x204\x20-\x207\x20days</strong>\x20of\x20starting\x20therapy\x20and\x20peak\x20in\x20about\x201\x20-\x201.5\x20weeks.\x20If\x20no\x20improvement\x20is\x20observed,\x20causes\x20like\x20poor\x20absorption,\x20noncompliance,\x20or\x20other\x20diagnoses\x20should\x20be\x20considered.</li>\x0a<li>To\x20test\x20absorption,\x20an\x20iron\x20tolerance\x20test\x20may\x20be\x20performed:\x20two\x20tablets\x20are\x20given\x20on\x20an\x20empty\x20stomach,\x20and\x20serum\x20iron\x20levels\x20are\x20monitored\x20for\x20a\x20rise\x20of\x20at\x20least\x20100\x20&micro;g/dL\x20over\x202-3\x20hours.\x20If\x20iron\x20deficiency\x20persists\x20despite\x20oral\x20therapy,\x20parenteral\x20iron\x20may\x20be\x20necessary.</li>\x0a</ul>','AGejX','<p><strong>Explanation:</strong></p>\x0a<ul>\x0a<li>Immunoglobulin\x20heavy\x20chains\x20(IGHV)\x20undergo\x20<strong>somatic\x20hypermutation</strong>,\x20and\x20~60%\x20of\x20patients\x20with\x20CLL\x20have\x20IGHV\x20that\x20is\x20<strong>&ge;2%\x20mutated</strong>\x20from\x20germline.</li>\x0a<li>This\x20may\x20indicate\x20a\x20<strong>more\x20mature,\x20postgerminal\x20center\x20progenitor</strong>,\x20and\x20is\x20typically\x20associated\x20with\x20a\x20<strong>more\x20indolent(silent/safe)\x20disease\x20course</strong>.</li>\x0a<li>Conversely,\x20~40%\x20of\x20patients\x20will\x20have\x20<strong>IGHV\x20&lt;2%\x20mutated</strong>\x20from\x20germline,\x20which\x20is\x20associated\x20with\x20<strong>more\x20rapid\x20progression\x20of\x20disease\x20and\x20short\x20survival</strong>\x20prior\x20to\x20the\x20era\x20of\x20therapeutics\x20that\x20target\x20BCR.</li>\x0a</ul>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024032791090d6b-8730-40fd-a0e4-d1dddb32c79a.jpg\x22><br>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403272cb37838-2c89-4111-aaf5-0a9db17f8d9a.jpg\x22>','addEventListener','CsoFR','Avdoe','length','wjGwj','BmluU','jsrLT','KIVDc','gdtHj','QHSrq','<p><span\x20style=\x22font-size:12.0pt;\x22>Empty\x20stomach</span></p>','<p><strong>Explanation:</strong></p>\x0a<p>Almost\x20all\x20hemoglobinopathies\x20are\x20<strong>autosomal\x20recessive</strong>\x20or\x20<strong>autosomal\x20co-dominant</strong>.</p>\x0a<ul>\x0a<li>Most\x20<strong>hemoglobin\x20disorders</strong>\x20are\x20inherited\x20in\x20an\x20autosomal\x20recessive\x20or\x20co-dominant\x20manner,\x20with\x20<strong>family\x20history</strong>\x20of\x20anemia\x20being\x20a\x20common\x20feature\x20among\x20affected\x20individuals,\x20especially\x20in\x20hemoglobinopathies\x20and\x20thalassemias.</li>\x0a<li>Clinical\x20signs\x20often\x20include<strong>\x20pallor</strong>,\x20<strong>jaundice</strong>,\x20and\x20splenomegaly.\x20In\x20sickle\x20cell\x20disease,\x20recurrent\x20painful\x20vaso-occlusive\x20crises\x20serve\x20as\x20a\x20key\x20diagnostic\x20clue.</li>\x0a<li>Diagnostic\x20evaluation\x20typically\x20begins\x20with\x20a\x20complete\x20blood\x20count,\x20including\x20a\x20reticulocyte\x20count\x20and\x20peripheral\x20smear\x20examination.</li>\x0a<li>A\x20persistently\x20<strong>elevated\x20reticulocyte\x20count\x20</strong>points\x20to\x20<strong>hemolytic\x20anemia</strong>.\x20Hemoglobin\x20variant\x20identification\x20through\x20techniques\x20like\x20<strong>high-performance\x20liquid\x20chromatography\x20(HPLC)\x20</strong>or\x20capillary\x20electrophoresis,\x20particularly\x20when\x20combined\x20with\x20analysis\x20of\x20relatives,\x20can\x20confirm\x20the\x20specific\x20hemoglobin\x20abnormality.</li>\x0a<li>Definitive\x20diagnosis\x20can\x20also\x20be\x20made\x20through\x20globin\x20gene\x20DNA\x20sequencing,\x20which\x20is\x20widely\x20available\x20and\x20essential\x20for\x20genetic\x20counseling.</li>\x0a</ul>','reduce','RdgIX','selectedAnswer','<p><span\x20style=\x22font-size:12.0pt;\x22>Whole\x20blood\x20is\x20stored\x20at\x20which\x20temperature\x20to\x20maintain\x20erythrocyte\x20viability?</span></p>','tFJmV','xikdI','QaPWH','ArrowLeft','<p><span\x20style=\x22font-size:12.0pt;\x22>Thalassemia</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Down\x20syndrome</span></p>','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','gHJKW','nLsMq','xTSab','wuzMr','DT1192233','LlQIU','zSanp','HCpBt','FLxXc','timerContainer','timed_study','NGELF','DT1192315','correctResult','question_video','bookmarkedQuestions','hZcrE','solutionContainer','add','JKfaF','LPtUX','mBfpI','fromCharCode','<p><span\x20style=\x22font-size:12.0pt;\x22>Used\x20in\x20Mantle\x20cell\x20lymphoma</span></p>','yCwrF','mcSeB','<p><span\x20style=\x22font-size:12.0pt;\x22>Serum\x20iron\x20&times;\x20100\x20&divide;\x20TIBC</span></p>','choices','nav-btn-correct','incomplete','YYosL','testModeReviewLegend','not-attempted','qPOYw','<p><span\x20style=\x22font-size:12.0pt;\x22>Chronic\x20neutrophilic\x20leukemia</span></p>','uOjBV','table','PNxNW','ceKvR','bVvEk','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','<p><span\x20style=\x22font-size:12.0pt;\x22>II\x20&\x20III</span></p>','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','CRBQe','toString','toISOString','dmRKK','VrgzJ','contains','src','<p><span\x20style=\x22font-size:12.0pt;\x22>Anti\x20CD52\x20monoclonal\x20antibody</span></p>','IifFi','.option-button','solution','ldBuf','NVIzt','<p><span\x20style=\x22font-size:12.0pt;\x22>All\x20of\x20above</span></p>','jojne','JjGLm','<p><strong>Explanation:</strong></p>\x0a<p><strong>Ponatinib</strong>\x20is\x20the\x20only\x20available\x20BCR-ABL1\x20tyrosine\x20kinase\x20inhibitor\x20<strong>active\x20against\x20T315I\x20mutation.</strong></p>\x0a<ul>\x0a<li><strong>Ponatinib</strong>\x20is\x20a\x20<strong>third\x20generation\x20tyrosine\x20kinase\x20inhibitor\x20</strong>effective\x20against\x20both\x20wild-type\x20and\x20mutant\x20forms\x20of\x20<strong>BCR/ABL1</strong>,\x20and\x20it\x20is\x20uniquely\x20active\x20against\x20the<strong>\x20T315I\x20mutation</strong>,\x20which\x20is\x20resistant\x20to\x20the\x20other\x20four\x20ATP-competitive\x20TKIs.</li>\x0a<li>It\x20is\x20approved\x20for\x20patients\x20who\x20have\x20not\x20responded\x20to\x20at\x20least\x20two\x20other\x20TKIs.</li>\x0a<li>In\x20addition\x20to\x20targeting\x20BCR-ABL1,\x20Ponatinib\x20also\x20blocks\x20<strong>vascular\x20endothelial\x20growth\x20factor\x20receptor\x20(VEGFR)</strong>,\x20which\x20likely\x20contributes\x20to\x20the\x20common\x20occurrence\x20of\x20<strong>hypertension</strong>\x20with\x20its\x20use.</li>\x0a<li>Other\x20reported\x20adverse\x20effects\x20include\x20pancreatitis,\x20skin\x20rashes,\x20and\x20arterio-occlusive\x20disease.</li>\x0a</ul>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403279fe7fd33-5a90-459c-8157-ac9dde7f57c2.jpg\x22>\x0a<p><strong>Explanations\x20of\x20other\x20options:</strong></p>\x0a<p><strong>Nilotinib\x20(Option\x20A):\x20</strong>Nilotinib\x20is\x20a\x20second-generation\x20tyrosine\x20kinase\x20inhibitor\x20approved\x20for\x20use\x20in\x20all\x20phases\x20of\x20chronic\x20myeloid\x20leukemia\x20(CML)\x20<strong>except\x20the\x20blastic\x20phase</strong>.\x20It\x20is\x20associated\x20with\x20toxicities\x20such\x20as\x20hyperglycemia,\x20hyperbilirubinemia,\x20pancreatitis,\x20and\x20cardiovascular\x20complications.\x20Nilotinib\x20is\x20also\x20preferred\x20in\x20cases\x20with\x20specific\x20mutations\x20such\x20as\x20V299L,\x20T315A,\x20and\x20F317L/F/I/C.</p>\x0a<p><strong>Bosutinib\x20(Option\x20C):\x20</strong>Bosutinib\x20is\x20a\x20<strong>second-generation\x20tyrosine\x20kinase\x20inhibitor\x20</strong>approved\x20for\x20all\x20phases\x20of\x20chronic\x20myeloid\x20leukemia\x20(CML).\x20It\x20is\x20generally\x20well\x20tolerated,\x20with\x20a\x20relatively\x20low\x20incidence\x20of\x20cardiovascular\x20events\x20compared\x20to\x20other\x20TKIs,\x20but\x20notable\x20side\x20effects\x20include\x20diarrhea,\x20liver\x20enzyme\x20elevations,\x20and\x20renal\x20dysfunction.\x20Bosutinib\x20is\x20also\x20preferred\x20in\x20patients\x20with\x20certain\x20BCR-ABL1\x20mutations\x20such\x20as\x20Y253H,\x20E255K/V,\x20and\x20F359V/C/I.</p>\x0a<p><strong>Dasatinib\x20(Option\x20D):\x20</strong>Dasatinib\x20is\x20a\x20tyrosine\x20kinase\x20inhibitor\x20approved\x20for\x20all\x20phases\x20of\x20chronic\x20myeloid\x20leukemia\x20(CML).\x20It\x20is\x20associated\x20with\x20side\x20effects\x20such\x20as\x20myelosuppression,\x20<strong>pleural</strong>\x20and\x20<strong>pericardial\x20effusions</strong>,\x20and\x20pulmonary\x20hypertension,\x20particularly\x20at\x20higher\x20doses.\x20Dasatinib\x20is\x20preferred\x20in\x20patients\x20with\x20BCR-ABL1\x20mutations\x20like\x20Y253H,\x20E255K/V,\x20and\x20F359V/C/I.</p>','MBqst','XBYGx','TGJds','question_audio','PBKwc','status','<p><strong>Explanation:</strong></p>\x0a<p>Accelerated\x20blast\x20phase\x20in\x20CML\x20is\x20characterized\x20by\x20<strong>&lt;100\x20&times;\x2010\x20raised\x20to\x209/L\x20unrelated\x20to\x20therapy.</strong></p>\x0a<ul>\x0a<li>CML\x20is\x20a\x20clonal\x20myeloproliferative\x20neoplasm\x20arising\x20from\x20hematopoietic\x20stem\x20cells.\x20Its\x20hallmark\x20is\x20the\x20<strong>BCR-ABL1\x20fusion\x20gene</strong>,\x20which\x20encodes\x20an\x20active\x20tyrosine\x20kinase.</li>\x0a<li>This\x20genetic\x20event\x20results\x20from\x20a\x20reciprocal\x20translocation\x20between\x20chromosomes\x209\x20and\x2022,\x20forming\x20the\x20Philadelphia\x20(Ph)\x20chromosome.</li>\x0a<li>Without\x20treatment,\x20CML\x20progresses\x20in\x20two\x20or\x20three\x20phases:\x20a\x20chronic\x20phase,\x20an\x20accelerated\x20phase,\x20and\x20a\x20terminal\x20blastic\x20phase.</li>\x0a<li>Most\x20patients\x20(90%)\x20are\x20in\x20the\x20chronic\x20phase\x20at\x20diagnosis,\x20often\x20asymptomatic.\x20When\x20symptoms\x20occur,\x20they\x20reflect\x20anemia\x20or\x20splenic\x20enlargement\x20such\x20as\x20fatigue,\x20malaise,\x20early\x20satiety,\x20<strong>left\x20upper\x20quadrant\x20discomfort</strong>,\x20or\x20weight\x20loss.\x20Thrombotic\x20complications\x20from\x20leukocytosis\x20or\x20thrombocytosis\x20may\x20also\x20arise,\x20with\x20effects\x20like\x20visual\x20disturbances,\x20priapism,\x20or\x20stroke.</li>\x0a<li><strong>Splenomegaly</strong>\x20is\x20the\x20most\x20frequent\x20finding\x20(20-70%),\x20followed\x20by\x20hepatomegaly,\x20lymphadenopathy,\x20or\x20skin\x20lesions\x20(suggesting\x20transformation).</li>\x0a<li>CML\x20can\x20transform\x20into\x20accelerated\x20or\x20blastic\x20phases.\x20Features\x20of\x20accelerated\x20phase\x20include\x20<strong>&ge;15%\x20blasts\x20in\x20blood</strong>,\x20<strong>&ge;30%\x20blasts</strong>\x20<strong>and\x20promyelocytes\x20combined</strong>,\x20<strong>&ge;20%\x20basophils</strong>,\x20new\x20cytogenetic\x20abnormalities\x20beyond\x20Philadelphia\x20chromosome\x20(cytogenetic\x20clonal\x20evaluation),\x20or\x20platelet\x20counts\x20<strong>&lt;100\x20&times;\x2010<sup>9</sup>/L\x20unrelated\x20to\x20therapy.\x20</strong>(Options\x20A,\x20B,\x20and\x20C\x20ruled\x20out)</li>\x0a</ul>','WzzAM','location','rBHsH','totalQuestions','GsnpL','EaBrz','UVqSi','test','bookmarkBtn','dtXhr','<p><span\x20style=\x22font-size:12.0pt;\x22>Deletion\x208</span></p>','eqRcE','<p><strong>Explanation:</strong></p>\x0a<p>Whole\x20blood\x20is\x20stored\x20at\x20<strong>\x204&deg;\x20C\x20</strong>to\x20maintain\x20erythrocyte\x20viability.</p>\x0a<ul>\x0a<li>Whole\x20blood\x20typically\x20has\x20a\x20volume\x20between\x20<strong>250\x20-300\x20mL</strong>,\x20including\x20additive\x20solution,\x20with\x20plasma\x20content\x20not\x20exceeding\x2040-50\x20mL.</li>\x0a<li>Hemoglobin\x20levels\x20range\x20from<strong>\x2012-20\x20g/dL</strong>,\x20hematocrit\x20is\x20between\x2050-70%,\x20and\x20hemolysis\x20should\x20be\x20&le;0.8%\x20at\x20the\x20time\x20of\x20issue.</li>\x0a<li>Whole\x20blood\x20is\x20stored\x20at\x204&plusmn;2&deg;C.\x20The\x20duration\x20depends\x20on\x20the\x20additive\x20solution\x20used,\x20usually\x20ranging\x20from\x20<strong>25\x20-\x2042\x20</strong>days<strong>.</strong>(Options\x20B,\x20C,\x20and\x20D\x20ruled\x20out)</li>\x0a<li><strong>Citrate\x20dextrose\x20phosphate\x20adenine-1\x20(CDPA-1)</strong>\x20serves\x20as\x20a\x20blood\x20preservative,\x20extending\x20storage\x20duration\x20up\x20to\x2035\x20days\x20by\x20enhancing\x20ATP\x20production\x20during\x20storage.</li>\x0a<li>This\x20prolongs\x20the\x20viability\x20of\x20stored\x20blood.\x20However,\x20a\x20drawback\x20of\x20CDPA-1\x20is\x20its\x20potential\x20to\x20promote\x20uric\x20acid\x20stone\x20formation.</li>\x0a<li>In\x20comparison,\x20blood\x20stored\x20with\x20other\x20preservatives\x20Citrate-Phosphate\x20Dextrose\x20has\x20a\x20shelf\x20life\x20of\x20<strong>21\x20days</strong>.</li>\x0a<li>If\x20the\x20blood\x20undergoes\x20irradiation,\x20storage\x20is\x20limited\x20to\x20<strong>24\x20hours.</strong></li>\x0a</ul>\x0a<p><strong>Reference:</strong></p>\x0a<p><a\x20href=\x22https://pubmed.ncbi.nlm.nih.gov/32187700/\x22\x20target=\x22_blank\x22>https://pubmed.ncbi.nlm.nih.gov/32187700/</a></p>\x0a<p><a\x20href=\x22https://pubmed.ncbi.nlm.nih.gov/6710583/\x22\x20target=\x22_blank\x22>https://pubmed.ncbi.nlm.nih.gov/6710583/</a></p>','map','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','tsLOo','rmGbO','totalAttempted','-600\x20text-white\x22>','iVTsO','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','YbfyE','QyoLb','gyuKD','error','questionText','OwVuF','REeOt','<p><span\x20style=\x22font-size:12.0pt;\x22>Neutrophils</span></p>','startAt','JTmNU','BFSrZ','jcBhC','eJJiI','<p><span\x20style=\x22font-size:12.0pt;\x22>Deletion\x205</span></p>','keydown','WSdwe','fGLAi','otKBF','endsWith','vpqGy','correctAnswers','LLcaI','console','parse','qlIwB','LtBTr','DNzwR','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','<p><span\x20style=\x22font-size:12.0pt;\x22>Primary\x20myelofibrosis</span></p>','ilFyn','No\x20question\x20text\x20available','JWhDi','Mark\x20for\x20Review','getElementById','<p><span\x20style=\x22font-size:12.0pt;\x22>Used\x20in\x20multiple\x20myeloma</span></p>','MzUwj','(((.+)+)+)+$','floor','incorrectAnswers','DOMContentLoaded','Dqfdl','<p><span\x20style=\x22font-size:12.0pt;\x22>I\x20&\x20II</span></p>','WBEjf','Medicine','ziRpQ','hUCqQ','UVCGJ','mdefO','mwNeq','jzMSL','PNgWB','vktsw','Xtvhn','<p><span\x20style=\x22font-size:12.0pt;\x22>Cervix\x20cancer</span></p>','correct_choice_id','oSAvF','eyBNh','timeSpent','myHju','VuOij','KMpdh','preventDefault','ukoHz','<p><span\x20style=\x22font-size:12.0pt;\x22>15%\x20or\x20more\x20peripheral\x20blasts</span></p>','GbfvH','TcVTx','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>','<p><span\x20style=\x22font-size:12.0pt;\x22>Poor\x20prognosis</span></p>','style','<p><span\x20style=\x22font-size:12.0pt;\x22>JAK\x202\x20mutation\x20is\x20seen\x20in\x20all\x20except?</span></p>','hematology-part-1-22d6ba39.html','EbnFt','not_attempted','pozef','width','solutionVideo','upESh','loadSource','Ugjgf','<p><span\x20style=\x22font-size:12.0pt;\x22>Lymphocytosis\x20along\x20with\x20lymphadenopathy</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Inj\x20Cytarabine\x20(100-200mg/m2)\x20+\x20Inj\x20Daunorubicin\x20(60-90\x20mg/m2)\x20[7+3\x20regimen]</span></p>','optionsContainer','ZSpbF','selected','SHRZk','statsBar','crVoh','HpDPK','\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>','dAgHh','incorrect','<p><span\x20style=\x22font-size:12.0pt;\x22>&le;\x206\x20cm\x20below\x20costal\x20margin\x20or\x20progressive\x20splenomegaly</span></p>','ODcKA','<p><span\x20style=\x22font-size:12.0pt;\x22>Hemoglobinopathies\x20are\x20usually?</span></p>','bihxq','GhOmQ','<p><strong>Explanation:</strong></p>\x0a<p>Cytogenetic\x20abnormalities\x20seen\x20in\x20myelodysplastic\x20syndromes\x20include\x20deletion\x205,\x20deletion\x207,\x20deletion\x2020,\x20and\x20<strong>trisomy\x208</strong>.</p>\x0a<ul>\x0a<li><strong>Myelodysplastic\x20syndromes\x20</strong>encompasses\x20a\x20varied\x20group\x20of\x20hematological\x20conditions\x20marked\x20by\x20bone\x20marrow\x20failure\x20resulting\x20in\x20cytopenias\x20and\x20a\x20heightened\x20risk\x20of\x20transformation\x20to\x20<strong>acute\x20myeloid\x20leukemia</strong>\x20(AML).</li>\x0a<li>Ineffective\x20blood\x20cell\x20production\x20leads\x20to\x20anemia,\x20often\x20with\x20low\x20platelet\x20and\x20neutrophil\x20counts.</li>\x0a<li>Abnormal\x20bone\x20marrow\x20features\x20and\x20chromosomal\x20mutations\x20are\x20common.\x20Low-risk\x20MDS\x20is\x20dominated\x20by\x20marrow\x20failure,\x20while\x20high-risk\x20types\x20involve\x20abnormal\x20chromosomes\x20and\x20myeloblasts,\x20with\x20potential\x20for\x20leukemic\x20transformation.</li>\x0a<li>MDS\x20is\x20more\x20fatal\x20due\x20to\x20complications\x20from\x20cytopenias\x20or\x20progression\x20to\x20leukemia,\x20although\x20many\x20patients\x20die\x20from\x20comorbid\x20conditions.</li>\x0a<li>MDS\x20typically\x20affects\x20the\x20<strong>elderly\x20</strong>(mean\x20age\x20&gt;70),\x20with\x20a\x20slight\x20male\x20bias.\x20t\x27s\x20uncommon\x20in\x20children,\x20where\x20it\x20often\x20has\x20a\x20genetic\x20basis.\x20<strong>Therapy-related\x20MDS</strong>,\x20usually\x20caused\x20by\x20chemotherapy\x20or\x20radiation,\x20is\x20not\x20age-related.</li>\x0a<li>MDS\x20arises\x20from\x20environmental\x20exposures\x20(e.g.,\x20radiation,\x20benzene)\x20or\x20as\x20a\x20delayed\x20consequence\x20of\x20cancer\x20treatments\x20like\x20alkylating\x20agents\x20and\x20DNA\x20topoisomerase\x20inhibitors.</li>\x0a<li>Some\x20<strong>hereditary\x20conditions</strong>\x20such\x20as\x20Fanconi\x20anemia,\x20GATA2,\x20RUNX1\x20mutations\x20may\x20evolve\x20into\x20MDS.</li>\x0a<li>MDS\x20originates\x20from\x20clonal\x20hematopoietic\x20stem\x20cell\x20disorders\x20marked\x20by\x20disrupted\x20cell\x20growth\x20and\x20maturation.\x20Genetic\x20changes\x20are\x20prevalent\x20in\x20both\x20AML\x20and\x20MDS,\x20including\x20chromosomal\x20losses\x20such\x20as\x20deletion\x205,7,20,\x20trisomy\x208,\x20and\x20mutations\x20in\x20genes\x20like\x20SF3B1,\x20TP53,\x20EZH2,\x20and\x20ASXL1.\x20(Options\x20A,\x20B,\x20and\x20D\x20ruled\x20out)</li>\x0a<li>These\x20genetic\x20changes\x20influence\x20prognosis\x20and\x20treatment\x20response.\x20Mutated\x20clones\x20evolve\x20over\x20time,\x20and\x20deep\x20sequencing\x20shows\x20successive\x20mutational\x20events\x20as\x20MDS\x20progresses\x20to\x20AML.</li>\x0a</ul>','edJOa','<p><span\x20style=\x22font-size:12.0pt;\x22>20%\x20or\x20more\x20peripheral\x20basophils</span></p>','NwRDc','closest','<p><strong>Explanation:</strong></p>\x0a<p>JAK2\x20mutation\x20is\x20not\x20seen\x20in\x20chronic\x20neutrophilic\x20leukemia\x20among\x20the\x20given\x20options:</p>\x0a<ul>\x0a<li><strong>JAK2\x20mutation\x20</strong>enriched\x20<strong>myeloproliferative\x20neoplasms\x20</strong>include:\x20Polycythemia\x20vera,\x20primary\x20myelofibrosis,\x20and\x20essential\x20thrombocythemia.(Options\x20A,\x20C,\x20and\x20D\x20ruled\x20out)</li>\x0a<li>JAK2,\x20a\x20tyrosine\x20kinase,\x20is\x20essential\x20for\x20the\x20function\x20of\x20the\x20erythropoietin\x20and\x20thrombopoietin\x20receptors\x20and\x20is\x20also\x20utilized\x20by\x20the\x20granulocyte\x20colony-stimulating\x20factor\x20(G-CSF)\x20receptor.</li>\x0a<li>Chronic\x20neutrophilic\x20leukemia\x20(CNL)\x20is\x20a\x20clonal\x20proliferation\x20of\x20mature\x20neutrophils\x20with\x20few\x20or\x20no\x20circulating\x20immature\x20granulocytes.</li>\x0a<li>CNL\x20was\x20described\x20to\x20be\x20associated\x20with\x20activating\x20mutations\x20of\x20the\x20CSF3R\x20gene\x20encoding\x20the\x20<strong>receptor\x20for\x20G-CSF</strong>,\x20also\x20known\x20as\x20colony-stimulating\x20factor\x203\x20(CSF3).</li>\x0a</ul>','hSsSc','data-option-index','onXWs','kEPgx','OlyFA','PNnjW','nPdrX','stats','<p><span\x20style=\x22font-size:12.0pt;\x22>Anti\x20CD\x2020\x20monoclonal\x20antibody</span></p>','sBvwK','BCWEz','tCIOI','No\x20solution\x20provided','dhpyG','correct','usxbH','<p><span\x20style=\x22font-size:12.0pt;\x22>None\x20of\x20the\x20above</span></p>','OGORB','<p><span\x20style=\x22font-size:12.0pt;\x22>Essential\x20thrombocytosis</span></p>','FSkxz','lflKt','<p><span\x20style=\x22font-size:12.0pt;\x22>Just\x20after\x20food</span></p>','qwphu','TeqTS','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','<p><span\x20style=\x22font-size:12.0pt;\x22>Colorectal\x20cancer</span></p>','kZvju','exception','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20is\x20the\x20most\x20efficient\x20antigen\x20presenting\x20cell?</span></p>','KnbLY','bind','VAqiX','classList','DbaVI','IXjzH','pop','IiUIn','UTrxg','getAttribute','study','<p><span\x20style=\x22font-size:12.0pt;\x22>Autosomal\x20codominant</span></p>','VuwXg','markReviewText','fCgwT','intermediate','KDvBd','none','niVtS','__proto__','iIGCG','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','EXsxy','LSlzp','ZEKnJ','xMLLx','strokeDashoffset','tQzoJ','accuracy','<p><span\x20style=\x22font-size:12.0pt;\x22>4&deg;\x20C</span></p>','get','apply','attachMedia','<p><span\x20style=\x22font-size:12.0pt;\x22>Hairy\x20cell\x20leukemia</span></p>','zPNYU','jPCVS','VjKSO','hidden','wxIdy','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20best\x20describes\x20rituximab?</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>Hypocellular\x20marrow\x20with\x20pancytopenia\x20seen\x20in?</span></p>','qwFYh','avgTimeResult','explanation_images','SrMmB','replace','MzbpC','<p><span\x20style=\x22font-size:12.0pt;\x22>All\x20of\x20the\x20above</span></p>','dPqeK','BIZJO','QGjHW','Jtvjz','removeItem','totalTimeResult','hjzzP','click','zhnIJ','IgzmK','border-green-500','NKTOz','solutionText','lXovx','custom_quiz.html','AWbRb','<p><strong>Explanation:</strong></p>\x0a<p>Rai\x20stage\x20III/IV\x20in\x20CLL\x20staging\x20among\x20the\x20given\x20options\x20is\x20<strong>lymphocytosis\x20along\x20with\x20anemia</strong>.</p>\x0a<p>Rai\x20and\x20Binet\x20classification\x20used\x20in\x20CLL\x20is\x20given\x20below.</p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250912002aa9bf-6bc6-42af-b6af-6cedd035bf82.png\x22><br>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025091286e417f2-9605-4832-88aa-dbcd33a22778.png\x22>','IUuRD','zphZh','No\x20solution\x20available.','referrer','<p><span\x20style=\x22font-size:12.0pt;\x22>I\x20&\x20III</span></p>','Bookmarked','3FqquGa','join','PZfoD','YakMg','<p><span\x20style=\x22font-size:12.0pt;\x22>Treatment\x20of\x20choice\x20in\x20young\x20patients\x20with\x20AML\x20is?</span></p>','<p><strong>Explanation:</strong></p>\x0a<p><strong>Kostmann\x20syndrome</strong>\x20causes\x20<strong>congenital\x20neutropenia</strong>,\x20due\x20to\x20<strong>mutations</strong>\x20in\x20the\x20genes\x20encoding\x20the\x20<strong>granulocyte\x20colony-stimulating\x20factor\x20receptor\x20and\x20neutrophil\x20elastase</strong>\x20and\x20may\x20evolve\x20into\x20AML.</p>\x0a<p>All\x20the\x20remaining\x20options\x20can\x20cause\x20aplastic\x20anemia.</p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240327ee77f823-e957-471f-92df-1867e0c772e5.jpg\x22>','ODUZA','gUzJz','<p><span\x20style=\x22font-size:12.0pt;\x22>Bosutinib</span></p>','GtaMB','padStart','answered','Previous\x20progress\x20cleared.','423631XfckYX','ambRN','correctCount','bsUgP','text','.m3u8','green','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','border-gray-600','dCnIU','GlJDf','AoUdp','<p><span\x20style=\x22font-size:12.0pt;\x22>Room\x20temperature</span></p>','ymibd','<p><span\x20style=\x22font-size:12.0pt;\x22>Aplastic\x20anemia\x20is\x20caused\x20by\x20all\x20except?</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>All\x20are\x20correct\x20about\x20bortezomib\x20except?</span></p>','CTwvN','DT1192328','HqHCC','DT1192291','QGXcU','DT1192266','CFnZD','findIndex','completed','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','WHvGn','sCuKr','ZnSEV','red','Jdscd','syGLv','questionIndex','DocTutorial','<p><span\x20style=\x22font-size:12.0pt;\x22>9</span></p>','iLApH','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','filter','CJvQX','explanation_audio_eng','<p><span\x20style=\x22font-size:12.0pt;\x22>No\x20relation\x20with\x20food</span></p>','384478fCbsgM','YJshL','Mttbv','display','xWmRX','KeqYw','Cezrp','Option\x20','iIzHz','nAAUb','includes','BbteV','now','remove','LKnbo','Progress\x20loaded.','tTttV','VTrfH','SxjFF','ajVzv','<p><span\x20style=\x22font-size:12.0pt;\x22>The\x20tyrosine\x20Kinase\x20Inhibitor\x20active\x20against\x20T315I\x20mutation\x20in\x20chronic\x20myeloid\x20leukemia\x20is?</span></p>','HdfsE','20LKhQoT','JuHRT','THCCF','gXZnK','vNPYK','rmkqn','Xzjuh','ohygk','bookmarked','border-red-500','BbAfb','<p><span\x20style=\x22font-size:12.0pt;\x22>Cytogenetic\x20abnormalities\x20seen\x20in\x20myelodysplastic\x20syndromes\x20include\x20all\x20except?</span></p>','FSbKr','nxkVX','apGsi','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','rwfoL','<p><span\x20style=\x22font-size:12.0pt;\x22>Cairo\x20bishop\x20criteria\x20include\x20all\x20of\x20the\x20following\x20except?</span></p>','search','split','return\x20(function()\x20','OzZGW','<p><strong>Explanation:</strong></p>\x0a<p><strong>Cairo\x20Bishop\x20criteria</strong>\x20for\x20the\x20diagnosis\x20of\x20<strong>tumor\x20lysis\x20Syndrome</strong>\x20(TLS)\x20includes\x20hyperphosphatemia,\x20hyperkalemia,\x20hyperuricemia,\x20and\x20<strong>hypocalcemia</strong>.</p>\x0a<ul>\x0a<li>Tumor\x20lysis\x20syndrome\x20(TLS)\x20arises\x20from\x20massive\x20lysis\x20of\x20tumor\x20cells,\x20typically\x20after\x20<strong>chemotherapy\x20</strong>in\x20rapidly\x20proliferating\x20cancers\x20such\x20as\x20Burkitt\x27s\x20lymphoma,\x20acute\x20lymphoblastic\x20leukemia,\x20and\x20some\x20chronic\x20leukemias.</li>\x0a<li>The\x20destruction\x20of\x20tumor\x20cells\x20leads\x20to\x20<strong>release\x20of\x20intracellular\x20contents</strong>\x20into\x20the\x20bloodstream,\x20causing\x20hyperuricemia,\x20hyperkalemia,\x20hyperphosphatemia,\x20and\x20hypocalcemia.\x20(Options\x20B,\x20C,\x20and\x20D\x20ruled\x20out)</li>\x0a<li>These\x20disturbances\x20can\x20precipitate\x20<strong>acute\x20renal\x20failure</strong>\x20due\x20to\x20uric\x20acid\x20and\x20calcium\x20phosphate\x20precipitation\x20in\x20renal\x20tubules.</li>\x0a<li>TLS\x20may\x20also\x20occur\x20spontaneously\x20or\x20after\x20treatments\x20like<strong>\x20monoclonal\x20antibodies\x20</strong>and\x20steroids.</li>\x0a<li>Laboratory\x20indicators\x20of\x20high\x20TLS\x20risk\x20include\x20elevated\x20uric\x20acid\x20and\x20lactate\x20dehydrogenase\x20(LDH\x20&gt;1500\x20U/L).</li>\x0a<li>Prevention\x20involves\x20<strong>hydration</strong>\x20and\x20agents\x20like<strong>\x20allopurinol\x20</strong>or\x20febuxostat\x20to\x20lower\x20uric\x20acid\x20levels.</li>\x0a<li><strong>Rasburicase</strong>,\x20a\x20recombinant\x20urate\x20oxidase,\x20is\x20especially\x20effective\x20but\x20contraindicated\x20in\x20G6PD\x20deficiency.</li>\x0a<li>In\x20some\x20cases,\x20renal\x20replacement\x20therapy,\x20particularly\x20hemodialysis,\x20is\x20needed.</li>\x0a<li>TLS\x20may\x20lead\x20to\x20complications\x20such\x20as\x20<strong>cardiac\x20arrhythmias</strong>,\x20tetany,\x20or\x20seizures,\x20requiring\x20vigilant\x20monitoring.</li>\x0a</ul>\x0a<p><strong>Reference:</strong></p>\x0a<p><a\x20href=\x22https://www.researchgate.net/figure/Cairo-Bishop-classification-of-tumor-lysis-syndrome-in-adults_tbl1_230645601\x22\x20target=\x22_blank\x22>https://www.researchgate.net/figure/Cairo-Bishop-classification-of-tumor-lysis-syndrome-in-adults_tbl1_230645601</a></p>','TmiyT','<p><span\x20style=\x22font-size:12.0pt;\x22>IGHV\x20(Immunoglobulin\x20heavy\x20chain)\x20mutation\x20in\x20CLL\x20is\x20indicative\x20of?</span></p>','textContent','ZGuye','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','hBYHv','zVgPf','QEYhd','mMuAC','KxtAf','div','uyyjA','jQjJN','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','eITUn','JsfFV','RPVyA','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','markedForReview','getItem','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','href','KFUxO','YbQal','qxRGJ','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','rDTBD','VFSdF','sqeuq','IImkM','TpNib','customQuizData','<p><span\x20style=\x22font-size:12.0pt;\x22>Deletion\x207</span></p>','nav-btn-answered','<p><span\x20style=\x22font-size:12.0pt;\x22>Polycythemia\x20vera</span></p>','jzpMR','RUTcS','Ryfnm','Bookmark','JJUhs'];_0x1ec7=function(){return _0x58d5a2;};return _0x1ec7();}function _0x3765(_0x419bb9,_0x1915e6){const _0x57dedf=_0x1ec7();return _0x3765=function(_0x14334b,_0x2a9346){_0x14334b=_0x14334b-0x1eb;let _0x1ba0f3=_0x57dedf[_0x14334b];return _0x1ba0f3;},_0x3765(_0x419bb9,_0x1915e6);}function updateMarkReviewButton(){const _0x5e930e=_0x554b79,_0x514b03={'LCcbR':_0x5e930e(0x2db),'ZEKnJ':_0x5e930e(0x389),'eqRcE':_0x5e930e(0x496),'HPaeT':_0x5e930e(0x3e4)},_0x44f9ef=document[_0x5e930e(0x26c)](_0x5e930e(0x4a1)),_0x47e114=document[_0x5e930e(0x26c)](_0x514b03['LCcbR']),_0x262572=questionStates[currentQuestionIndex]['markedForReview'];_0x44f9ef[_0x5e930e(0x3ff)]=_0x262572?_0x514b03[_0x5e930e(0x2e6)]:_0x514b03[_0x5e930e(0x241)],_0x47e114[_0x5e930e(0x37a)]=_0x262572?_0x514b03[_0x5e930e(0x434)]:_0x5e930e(0x26b);}function previousQuestion(){const _0xc471b8=_0x554b79,_0x3ca9a7={'KeqYw':function(_0x389943,_0x1c9fb3){return _0x389943>_0x1c9fb3;},'RUTcS':function(_0xfab132,_0x37e3fc){return _0xfab132===_0x37e3fc;},'FLxXc':_0xc471b8(0x438),'yPpfN':function(_0x57ec44,_0x26ebd6){return _0x57ec44-_0x26ebd6;},'DlQrj':function(_0x26fbb5){return _0x26fbb5();}};_0x3ca9a7[_0xc471b8(0x350)](currentQuestionIndex,0x0)&&(_0x3ca9a7[_0xc471b8(0x39c)](_0x3ca9a7[_0xc471b8(0x1fb)],_0x3ca9a7[_0xc471b8(0x1fb)])?(questionStartTime&&(questionStates[currentQuestionIndex][_0xc471b8(0x284)]+=_0x3ca9a7['yPpfN'](Date[_0xc471b8(0x357)](),questionStartTime)),currentQuestionIndex--,displayQuestion(),_0x3ca9a7['DlQrj'](saveProgress)):_0x2e90bb[_0xc471b8(0x224)]=_0x1c4a7e);}function nextQuestion(){const _0x3ace26=_0x554b79,_0x377e6b={'fXUpO':function(_0x25bf73){return _0x25bf73();},'xSsAI':function(_0x4d120a){return _0x4d120a();},'yXOXU':function(_0x4e194f,_0x15119b){return _0x4e194f(_0x15119b);},'uKaEF':function(_0x3d61d8,_0x5480e7){return _0x3d61d8+_0x5480e7;},'Cezrp':_0x3ace26(0x477),'lbgnx':function(_0xadc1c2){return _0xadc1c2();},'MzUwj':'log','BkaiF':'warn','iCIuY':_0x3ace26(0x42b),'rXUBp':'error','sEPGD':'exception','TeqTS':_0x3ace26(0x217),'KeIPb':function(_0x498a9a,_0x3ba335){return _0x498a9a<_0x3ba335;},'YYosL':function(_0x58fdb6,_0xfdfb12){return _0x58fdb6-_0xfdfb12;},'CZcyp':function(_0x4e647c,_0x1fd2e5){return _0x4e647c<_0x1fd2e5;},'dUwCP':_0x3ace26(0x2d0),'AwlhT':_0x3ace26(0x43b),'KDvBd':function(_0x12efe3){return _0x12efe3();},'tsLOo':function(_0x427d09){return _0x427d09();},'oyUYQ':function(_0x54af44,_0xeebadd){return _0x54af44===_0xeebadd;},'ouays':_0x3ace26(0x23d),'oQXTE':_0x3ace26(0x408),'lflKt':function(_0x474a61,_0x4c2538){return _0x474a61!==_0x4c2538;},'lNJyq':_0x3ace26(0x28b),'xTSab':function(_0x59fb29,_0x57eb3a){return _0x59fb29(_0x57eb3a);},'ZnSEV':_0x3ace26(0x37c),'UYKoo':function(_0x31de15,_0x16ea1b){return _0x31de15!==_0x16ea1b;},'zjPxw':_0x3ace26(0x2be),'HCpBt':_0x3ace26(0x4c9),'MkOXQ':_0x3ace26(0x3b7),'YZmce':function(_0xe29098,_0x2c60d7){return _0xe29098(_0x2c60d7);},'DbgOM':_0x3ace26(0x391),'FSbKr':function(_0x935df){return _0x935df();}};questionStartTime&&(questionStates[currentQuestionIndex][_0x3ace26(0x284)]+=_0x377e6b[_0x3ace26(0x211)](Date['now'](),questionStartTime));if(_0x377e6b[_0x3ace26(0x4a0)](currentQuestionIndex,questionsData[_0x3ace26(0x4bf)]-0x1))_0x377e6b[_0x3ace26(0x435)]!==_0x377e6b['AwlhT']?(currentQuestionIndex++,_0x377e6b[_0x3ace26(0x2de)](displayQuestion),_0x377e6b[_0x3ace26(0x245)](saveProgress)):_0x377e6b['fXUpO'](_0xd4a528);else{if(_0x377e6b['oyUYQ'](currentMode,_0x377e6b['ouays'])||currentMode===_0x377e6b['oQXTE']){if(_0x377e6b[_0x3ace26(0x2c5)](_0x377e6b[_0x3ace26(0x432)],_0x377e6b[_0x3ace26(0x432)]))_0x377e6b['xSsAI'](_0x3ad429);else{if(_0x377e6b[_0x3ace26(0x1f5)](confirm,_0x377e6b[_0x3ace26(0x33e)])){if(_0x377e6b[_0x3ace26(0x3fe)](_0x3ace26(0x4b2),_0x377e6b[_0x3ace26(0x3a1)]))submitQuiz();else{let _0x5b583c;try{const _0x51bb5c=YHbilb[_0x3ace26(0x412)](_0x38997c,YHbilb[_0x3ace26(0x401)](YHbilb[_0x3ace26(0x401)]('return\x20(function()\x20',YHbilb[_0x3ace26(0x351)]),');'));_0x5b583c=YHbilb['lbgnx'](_0x51bb5c);}catch(_0x19eaf3){_0x5b583c=_0x21fd7f;}const _0x3d8a2e=_0x5b583c['console']=_0x5b583c['console']||{},_0x22c6a9=[YHbilb[_0x3ace26(0x26e)],YHbilb[_0x3ace26(0x3bb)],YHbilb[_0x3ace26(0x3ec)],YHbilb[_0x3ace26(0x3f9)],YHbilb[_0x3ace26(0x3ae)],YHbilb[_0x3ace26(0x2c8)],_0x3ace26(0x3c1)];for(let _0x2bf29f=0x0;YHbilb[_0x3ace26(0x439)](_0x2bf29f,_0x22c6a9[_0x3ace26(0x4bf)]);_0x2bf29f++){const _0x704b2c=_0x4666b0[_0x3ace26(0x3a4)][_0x3ace26(0x471)][_0x3ace26(0x2cf)](_0x326667),_0x276f87=_0x22c6a9[_0x2bf29f],_0x1ceb52=_0x3d8a2e[_0x276f87]||_0x704b2c;_0x704b2c[_0x3ace26(0x2e1)]=_0x57cb9e[_0x3ace26(0x2cf)](_0x56a9e9),_0x704b2c[_0x3ace26(0x21f)]=_0x1ceb52['toString'][_0x3ace26(0x2cf)](_0x1ceb52),_0x3d8a2e[_0x276f87]=_0x704b2c;}}}}}else _0x377e6b[_0x3ace26(0x3fe)](_0x377e6b[_0x3ace26(0x1fa)],_0x377e6b['MkOXQ'])?_0x377e6b['YZmce'](confirm,_0x377e6b[_0x3ace26(0x459)])&&(currentQuestionIndex=0x0,_0x377e6b[_0x3ace26(0x36d)](displayQuestion),saveProgress()):_0x9e6d16[_0x3ace26(0x26c)](_0x3ace26(0x1fc))[_0x3ace26(0x2d1)][_0x3ace26(0x358)]('hidden');}}function startTimer(){const _0x42a588=_0x554b79,_0x4892a1={'dtXhr':_0x42a588(0x37c),'XAotQ':function(_0x4cb729){return _0x4cb729();},'mwNeq':function(_0x5f1266){return _0x5f1266();},'TpNib':function(_0x1bacf9,_0x469b52){return _0x1bacf9<=_0x469b52;},'hBYHv':_0x42a588(0x2e4),'eJJiI':function(_0x2ff380,_0x5846f9){return _0x2ff380(_0x5846f9);},'mdefO':_0x42a588(0x408),'hvayb':function(_0x51aecb){return _0x51aecb();},'syGLv':function(_0x2fce21,_0x1b24dd){return _0x2fce21(_0x1b24dd);},'kFSIY':function(_0x5b9eb6){return _0x5b9eb6();}};if(timer)_0x4892a1[_0x42a588(0x341)](clearInterval,timer);timeRemaining=0x78,_0x4892a1[_0x42a588(0x3c2)](updateTimerDisplay),timer=setInterval(()=>{const _0x360fd5=_0x42a588;timeRemaining--,_0x4892a1[_0x360fd5(0x27b)](updateTimerDisplay),_0x4892a1[_0x360fd5(0x396)](timeRemaining,0x0)&&(_0x4892a1[_0x360fd5(0x37d)]!=='mhtRA'?(_0x4892a1[_0x360fd5(0x257)](clearInterval,timer),currentMode===_0x4892a1[_0x360fd5(0x27a)]?_0x4892a1[_0x360fd5(0x27b)](submitQuiz):_0x4892a1['hvayb'](nextQuestion)):_0x2793c9(_0x4892a1[_0x360fd5(0x23f)])&&_0x4892a1['XAotQ'](_0x54406c));},0x3e8);}function updateTimerDisplay(){const _0x10a256=_0x554b79,_0xdd927c={'wpSex':function(_0x48eaf3,_0x5029f2){return _0x48eaf3/_0x5029f2;},'Xdoga':function(_0x549067,_0x19d43b){return _0x549067%_0x19d43b;},'ckcfZ':'timeDisplay','SgWdi':function(_0x5463b5,_0x4818be){return _0x5463b5+_0x4818be;},'UTrxg':function(_0xcc7fa3,_0x35a59e){return _0xcc7fa3+_0x35a59e;}},_0x409212=Math[_0x10a256(0x270)](_0xdd927c[_0x10a256(0x3d2)](timeRemaining,0x3c)),_0x255a33=_0xdd927c['Xdoga'](timeRemaining,0x3c);document[_0x10a256(0x26c)](_0xdd927c[_0x10a256(0x4ad)])[_0x10a256(0x37a)]=_0xdd927c[_0x10a256(0x3b5)](_0xdd927c[_0x10a256(0x2d6)](_0x409212,':'),_0x255a33['toString']()['padStart'](0x2,'0'));}function toggleSidebar(){const _0x35bc5e=_0x554b79,_0x48a56f={'kigsi':_0x35bc5e(0x467)};document[_0x35bc5e(0x26c)](_0x48a56f['kigsi'])[_0x35bc5e(0x2d1)][_0x35bc5e(0x46a)](_0x35bc5e(0x4aa));}document['addEventListener'](_0x554b79(0x272),()=>{const _0x37d97a=_0x554b79,_0x4e0866={'XqmpL':function(_0x48e063){return _0x48e063();},'IOqWu':'modeModal','NlXOp':function(_0x7b4021){return _0x7b4021();},'KOgBN':'flex','HynyC':function(_0x54831b){return _0x54831b();},'xikdI':_0x37d97a(0x2df),'ysEeX':function(_0x2d8486,_0x89e434){return _0x2d8486!==_0x89e434;},'pTDGA':_0x37d97a(0x216),'ajVzv':_0x37d97a(0x452),'zSanp':function(_0x37db4a){return _0x37db4a();},'jPCVS':_0x37d97a(0x30c),'fSJzp':function(_0x15abb9,_0x2eae34){return _0x15abb9===_0x2eae34;},'qoNGB':'Taqjn','qwFYh':function(_0x53a99a){return _0x53a99a();},'qTFRy':function(_0xd5c3c4){return _0xd5c3c4();}};if(resume)_0x4e0866[_0x37d97a(0x422)](loadProgress)?(document['getElementById'](_0x4e0866['IOqWu'])['style'][_0x37d97a(0x34e)]=_0x4e0866[_0x37d97a(0x1ed)],_0x4e0866[_0x37d97a(0x3ca)](initializeQuiz)):_0x4e0866['ysEeX'](_0x4e0866[_0x37d97a(0x474)],_0x4e0866[_0x37d97a(0x35e)])?(_0x4e0866[_0x37d97a(0x1f9)](clearProgress),document['getElementById'](_0x4e0866[_0x37d97a(0x44e)])[_0x37d97a(0x28f)][_0x37d97a(0x34e)]=_0x4e0866[_0x37d97a(0x3ce)]):_0x339214();else!window['location']['pathname'][_0x37d97a(0x25d)](_0x4e0866[_0x37d97a(0x2f1)])?_0x4e0866[_0x37d97a(0x472)](_0x37d97a(0x3c6),_0x4e0866['qoNGB'])?(_0x4e0866[_0x37d97a(0x2f7)](clearProgress),document[_0x37d97a(0x26c)](_0x4e0866[_0x37d97a(0x44e)])[_0x37d97a(0x28f)]['display']=_0x37d97a(0x476)):_0x4e0866['XqmpL'](_0x1c69e)?(_0xd3838f[_0x37d97a(0x26c)](_0x4e0866['IOqWu'])[_0x37d97a(0x28f)][_0x37d97a(0x34e)]=_0x37d97a(0x2df),_0x4e0866['XqmpL'](_0x405890)):(_0x4e0866[_0x37d97a(0x3ca)](_0x51716d),_0xd93ab1[_0x37d97a(0x26c)](_0x4e0866['IOqWu'])['style'][_0x37d97a(0x34e)]=_0x4e0866[_0x37d97a(0x3ce)]):_0x4e0866[_0x37d97a(0x47b)](initializeQuiz);}),document[_0x554b79(0x4bc)](_0x554b79(0x259),function(_0x30fab9){const _0x2a7851=_0x554b79,_0x3d453e={'htNhW':function(_0x4a4ecc,_0x128511){return _0x4a4ecc(_0x128511);},'hYKjX':function(_0x59c3a0,_0x1984e8){return _0x59c3a0+_0x1984e8;},'eqFOX':'return\x20(function()\x20','QHror':_0x2a7851(0x477),'BCWEz':function(_0x295c72,_0x1d3f2a){return _0x295c72<_0x1d3f2a;},'LEvtT':_0x2a7851(0x202),'JkCFE':_0x2a7851(0x46e),'iIGCG':_0x2a7851(0x2df),'MzbpC':function(_0x5b6c15,_0x5f2b48){return _0x5b6c15===_0x5f2b48;},'KYauX':'performanceModal','EaBrz':'hidden','xzODT':function(_0x50074c,_0x2de89d){return _0x50074c>=_0x2de89d;},'rmGbO':function(_0x4a0875,_0x5e1c3b){return _0x4a0875-_0x5e1c3b;},'mEdCO':'.option-button','JTmNU':function(_0x56e7ee,_0x2a1834){return _0x56e7ee<_0x2a1834;},'NVIzt':_0x2a7851(0x1ef),'QpRAR':function(_0x631dd){return _0x631dd();},'dPqeK':'fGLAi','hxUUx':function(_0x3ead7a){return _0x3ead7a();},'Hmelx':function(_0x34bbc9,_0x4f7f52){return _0x34bbc9===_0x4f7f52;},'jGAkf':_0x2a7851(0x2d8),'oSAvF':function(_0x547665,_0x3ad23e){return _0x547665===_0x3ad23e;},'YbQal':'oCoaN','wIoHQ':function(_0x58fba1){return _0x58fba1();},'KjqUN':function(_0x19f312,_0x5d2f00){return _0x19f312===_0x5d2f00;},'aiDZT':function(_0x17867f,_0xa4dc1f){return _0x17867f===_0xa4dc1f;},'otKBF':_0x2a7851(0x23d),'hSsSc':_0x2a7851(0x408),'dLAVV':function(_0x88aef4){return _0x88aef4();},'PZfoD':function(_0x51aa25,_0x3fa127){return _0x51aa25===_0x3fa127;},'IImkM':_0x2a7851(0x22f)};if(document[_0x2a7851(0x26c)](_0x3d453e['JkCFE'])[_0x2a7851(0x28f)]['display']!==_0x3d453e[_0x2a7851(0x2e2)])return;if(_0x3d453e[_0x2a7851(0x2fc)](document[_0x2a7851(0x26c)](_0x3d453e['KYauX'])[_0x2a7851(0x2d1)][_0x2a7851(0x223)](_0x3d453e[_0x2a7851(0x23b)]),![]))return;if(_0x3d453e['xzODT'](_0x30fab9[_0x2a7851(0x448)],'1')&&_0x30fab9['key']<='4'){const _0x229514=_0x3d453e[_0x2a7851(0x246)](parseInt(_0x30fab9[_0x2a7851(0x448)]),0x1),_0x111a57=document[_0x2a7851(0x443)](_0x3d453e[_0x2a7851(0x49d)]);if(_0x3d453e[_0x2a7851(0x254)](_0x229514,_0x111a57[_0x2a7851(0x4bf)]))selectOption(_0x229514);}else{if(_0x3d453e[_0x2a7851(0x2fc)](_0x30fab9[_0x2a7851(0x448)],_0x3d453e[_0x2a7851(0x22a)]))_0x3d453e[_0x2a7851(0x3de)](previousQuestion);else{if(_0x3d453e[_0x2a7851(0x2fc)](_0x30fab9[_0x2a7851(0x448)],'ArrowRight')||_0x3d453e['MzbpC'](_0x30fab9[_0x2a7851(0x448)],'\x20')){if(_0x3d453e[_0x2a7851(0x2fe)]!==_0x2a7851(0x25b)){const _0x3111e4=yDqjBS['htNhW'](_0x433852,yDqjBS[_0x2a7851(0x490)](yDqjBS['hYKjX'](yDqjBS['eqFOX'],yDqjBS['QHror']),');'));_0x204a19=_0x3111e4();}else _0x30fab9[_0x2a7851(0x288)](),_0x3d453e[_0x2a7851(0x413)](nextQuestion);}else{if(_0x3d453e[_0x2a7851(0x2fc)](_0x30fab9['key'][_0x2a7851(0x41c)](),'b')&&(_0x3d453e[_0x2a7851(0x4ac)](currentMode,_0x3d453e['jGAkf'])||_0x3d453e[_0x2a7851(0x4ac)](currentMode,_0x2a7851(0x1fd)))){if(_0x3d453e[_0x2a7851(0x282)](_0x3d453e['YbQal'],_0x3d453e[_0x2a7851(0x38f)]))_0x3d453e['wIoHQ'](toggleBookmark);else{const _0x58fcc7=_0x44f6b8['parse'](_0x7f18bb[_0x2a7851(0x38b)](_0x3d453e['LEvtT']))||[];_0x58fcc7[_0x2a7851(0x442)](_0x6841a1=>{const _0x4ace09=_0x2a7851;_0x6841a1[_0x4ace09(0x42e)][_0x4ace09(0x355)](_0x203cdf['toLowerCase']()['replace'](/ /g,'-'))&&(_0x3d453e[_0x4ace09(0x2bb)](_0x6841a1['questionIndex'],_0x1d8b5a[_0x4ace09(0x4bf)])&&(_0x487208[_0x6841a1[_0x4ace09(0x342)]][_0x4ace09(0x369)]=!![]));});}}else{if(_0x3d453e[_0x2a7851(0x3fa)](_0x30fab9[_0x2a7851(0x448)]['toLowerCase'](),'m')&&(_0x3d453e['aiDZT'](currentMode,_0x3d453e[_0x2a7851(0x25c)])||_0x3d453e['aiDZT'](currentMode,_0x3d453e[_0x2a7851(0x2b1)])))_0x3d453e['dLAVV'](toggleMarkForReview);else{if(_0x3d453e[_0x2a7851(0x317)](_0x30fab9['key']['toLowerCase'](),'s')&&(currentMode==='test'||_0x3d453e['Hmelx'](currentMode,_0x3d453e[_0x2a7851(0x2b1)]))){if(_0x3d453e[_0x2a7851(0x395)]===_0x2a7851(0x22f))submitQuiz();else{if(_0x56ee2c){const _0x3b41a9=_0x493cec['apply'](_0x1b3e4d,arguments);return _0x5b91fc=null,_0x3b41a9;}}}}}}}}});</script>

</body></html>